Vorinostat (SAHA)

For research use only. Not for use in humans.

目录号：S1047 别名： MK0683

Molecular Weight(MW): 264.3

Vorinostat (suberoylanilide hydroxamic acid, SAHA)是一种HDAC抑制剂，无细胞试验中IC50为~10 nM。Vorinostat 会抑制高效的HPV-18 DNA扩增。

规格

价格

库存

购买数量

10mM (1mL in DMSO)	RMB 1558.77	现货
200mg	RMB 1198.15	现货
500mg	RMB 1794.86	现货
大包装	有超大折扣

大剂量询单有大折扣！

今日订购，明日送达，全国免运费！

全国免费电话：400-668-6834 | Email：info@selleck.cn

客户使用Selleck生产的Vorinostat (SAHA)发表文献309篇：

Nat Biotechnol, 2020, 10.1038/s41587-019-0388-4

PubMed: 31959954 ( click the link to review the publication )

Cancer Cell, 2020, 13;37(4):599-617 e7

PubMed: 32243837 ( click the link to review the publication )

Cell, 2019, 176(1-2):198-212

PubMed: 30503211 ( click the link to review the publication )

Cell, 2019, 36(2):179-193

PubMed: 28162770 ( click the link to review the publication )

Cancer Cell, 2019, 36(2):179-193

PubMed: 31378681 ( click the link to review the publication )

Cell, 2018, 174(3):536-548.e21

PubMed: 29961578 ( click the link to review the publication )

Cell Metab, 2018, 5;27(6):1294-1308.e7

PubMed: 29754954 ( click the link to review the publication )

Nature, 2017, 551(7679):247-250

PubMed: 29088702 ( click the link to review the publication )

Cancer Discov, 2017, 7(12):1450-1463

PubMed: 28963352 ( click the link to review the publication )

Cancer Cell, 2016, 29(3):311-323

PubMed: 26977882 ( click the link to review the publication )

Nat Biotechnol, 2015, 10.1038/nbt.3130

PubMed: 25751058 ( click the link to review the publication )

Nat Med, 2015, 21(10):1163-71

PubMed: 26390243 ( click the link to review the publication )

Nat Med, 2015, 10.1038/nm.3855

PubMed: 25939062 ( click the link to review the publication )

Cell, 2014, 28;158(5):989-999.

PubMed: 25131989 ( click the link to review the publication )

Nature, 2011, 10;471(7337):235-9.

PubMed: 21390130 ( click the link to review the publication )

Nat Biotechnol, 2011, 29(3):255-65

PubMed: 21258344 ( click the link to review the publication )

Nucleic Acids Res, 2020, 10.1093/nar/gkaa088

PubMed: 32107550 ( click the link to review the publication )

EMBO Rep, 2020, 21:e50162

PubMed: 32314873 ( click the link to review the publication )

J Immunother Cancer, 2020, 8(1)

PubMed: 31940587 ( click the link to review the publication )

Theranostics, 2020, 1;10(3):1433-1453

PubMed: 31938073 ( click the link to review the publication )

Cancer, 2020, 1;126(9):2024-2033

PubMed: 31999837 ( click the link to review the publication )

PLoS Pathog, 2020, 16;16(3):e1008341

PubMed: 32176725 ( click the link to review the publication )

Clin Epigenetics, 2020, 12(1):13

PubMed: 31941522 ( click the link to review the publication )

Br J Cancer, 2020, 27

PubMed: 32336756 ( click the link to review the publication )
Front Cell Dev Biol, 2020, 17;8:158

PubMed: 32258036 ( click the link to review the publication )

J Neuroinflammation, 2020, 22;17(1):125

PubMed: 32321538 ( click the link to review the publication )

ACS Infect Dis, 2020, 29

PubMed: 32347704 ( click the link to review the publication )

Mol Cancer Res, 2020, 10.1158/1541-7786.MCR-19-0669

PubMed: 32238439 ( click the link to review the publication )

Front Oncol, 2020, 10:296

PubMed: 32195191 ( click the link to review the publication )

J Virol, 2020, 4;94(10) pii: e01923-19

PubMed: 32161174 ( click the link to review the publication )

Biochem Pharmacol, 2020, 3;178:114067

PubMed: 32504550 ( click the link to review the publication )

Cancer Cell Int, 2020, 19;20:58

PubMed: 32099531 ( click the link to review the publication )

BMC Microbiol, 2020, 20(1):28

PubMed: 32028887 ( click the link to review the publication )

PLoS One, 2020, 15;15(5):e0232985

PubMed: 32413049 ( click the link to review the publication )

Oncol Lett, 2020, 19(1):460-468

PubMed: 31897159 ( click the link to review the publication )

Colloids Surf B Biointerfaces, 2020, 188:110753

PubMed: 31884084 ( click the link to review the publication )

Mol Cancer Ther, 2020, 19(2):637-649

PubMed: 31784455 ( click the link to review the publication )

Genes Dev, 2020, 34(5-6):428-445

PubMed: 32001510 ( click the link to review the publication )

Life Sci, 2020, 248:117469

PubMed: 32109485 ( click the link to review the publication )

Chin Med J (Engl), 2020, 5;133(11):1304-1311

PubMed: 32452893 ( click the link to review the publication )

Pharm Biol, 2020, 58(1):231-238

PubMed: 32202448 ( click the link to review the publication )

Nat Commun, 2019, 10(1):4192

PubMed: 31519896 ( click the link to review the publication )

J Pineal Res, 2019, 66(3):e12556

PubMed: 30648757 ( click the link to review the publication )

Haematologica, 2019, 10.3324/haematol.2018.211110

PubMed: 30846494 ( click the link to review the publication )

Haematologica, 2019, 104(11):2225-2240

PubMed: 30819918 ( click the link to review the publication )

Theranostics, 2019, 9(2):540-553

PubMed: 30809292 ( click the link to review the publication )

Cancer Res, 2019, 79(7):1658-1670

PubMed: 30737231 ( click the link to review the publication )

Cell Rep, 2019, 27(11):3331-3344

PubMed: 31189115 ( click the link to review the publication )
Elife, 2019, 8

PubMed: 30652970 ( click the link to review the publication )

Mol Ther, 2019, 27(5):1039-1050

PubMed: 30852137 ( click the link to review the publication )

Cancers (Basel), 2019, 11(4)

PubMed: 30935067 ( click the link to review the publication )

Clin Epigenetics, 2019, 11(1):85

PubMed: 31142371 ( click the link to review the publication )

Acta Pharm Sin B, 2019, 9(5):937-951

PubMed: 31649844 ( click the link to review the publication )

Cells, 2019, 8(12)

PubMed: 31795298 ( click the link to review the publication )

Cancer Discov, 2019, 9(4):526-545

PubMed: 30709805 ( click the link to review the publication )

Front Immunol, 2019, 9:3162

PubMed: 30723480 ( click the link to review the publication )

Mol Cancer Ther, 2019, 18(5):900-908

PubMed: 30824609 ( click the link to review the publication )

Mol Oncol, 2019, 10.1002/1878-0261.12607

PubMed: 31782885 ( click the link to review the publication )

Epigenetics, 2019, 10.1080/15592294.2019.1656155

PubMed: 31423895 ( click the link to review the publication )

Epigenetics, 2019, 14(8):791-803

PubMed: 31088315 ( click the link to review the publication )

Epigenetics, 2019, 10.1080/15592294.2019.1656156

PubMed: 31423932 ( click the link to review the publication )

AIDS, 2019, 33(2):199-209

PubMed: 30562171 ( click the link to review the publication )

Hum Mol Genet, 2019, 10.1093/hmg/ddz254

PubMed: 31691806 ( click the link to review the publication )

Pharmacol Res, 2019, 139:524-534

PubMed: 30366100 ( click the link to review the publication )

Pharmacol Res, 2019, 146:104281

PubMed: 31125601 ( click the link to review the publication )

J Neurochem, 2019, 10.1111/jnc.14935

PubMed: 31811660 ( click the link to review the publication )

Mol Pharm, 2019, 16(9):3904-3915

PubMed: 31318566 ( click the link to review the publication )

Bone, 2019, 125:112-121

PubMed: 31100533 ( click the link to review the publication )

Front Cell Neurosci, 2019, 13:468

PubMed: 31708743 ( click the link to review the publication )

Int J Mol Sci, 2019, 20(13)

PubMed: 31269745 ( click the link to review the publication )

Apoptosis, 2019, 24(5-6):404-413

PubMed: 30997620 ( click the link to review the publication )

J Biol Chem, 2019, 294(12):4437-4449

PubMed: 30670592 ( click the link to review the publication )
Acta Pharmacol Sin, 2019, 40(5):677-688

PubMed: 30224636 ( click the link to review the publication )

NMR Biomed, 2019, 32(2):e4044

PubMed: 30561869 ( click the link to review the publication )

Stem Cells Dev, 2019, 28(7):438-453

PubMed: 30667343 ( click the link to review the publication )

Chem Biol Interact, 2019, 306:54-61

PubMed: 30958996 ( click the link to review the publication )

Gene Ther, 2019, 26(3-4):75-85

PubMed: 30538307 ( click the link to review the publication )

Cancer Med, 2019, 8(14):6383-6392

PubMed: 31456359 ( click the link to review the publication )

Tuberculosis (Edinb), 2019, 118:101861

PubMed: 31526947 ( click the link to review the publication )

PLoS One, 2019, 14(6):e0218382

PubMed: 31206526 ( click the link to review the publication )

Exp Hematol, 2019, 72:60-71

PubMed: 30769020 ( click the link to review the publication )

Nucl Med Biol, 2019, 74-75:1-11

PubMed: 31421440 ( click the link to review the publication )

Alcohol, 2019, 78:79-87

PubMed: 30851364 ( click the link to review the publication )

Anticancer Res, 2019, 39(7):3579-3584

PubMed: 31262882 ( click the link to review the publication )

Res Vet Sci, 2019, 126:207-212

PubMed: 31610471 ( click the link to review the publication )

Exp Ther Med, 2019, 17(6):4547-4553

PubMed: 31186678 ( click the link to review the publication )

Medicina (Kaunas), 2019, 55(2)

PubMed: 30700046 ( click the link to review the publication )

Cell Host Microbe, 2018, 24(5):689-702

PubMed: 30344003 ( click the link to review the publication )

Nat Commun, 2018, 13;9(1):2720

PubMed: 30006524 ( click the link to review the publication )

Clin Cancer Res, 2018, 24(16):3941-3954

PubMed: 29764852 ( click the link to review the publication )

Cancer Res, 2018, 78(10):2705-2720

PubMed: 29490948 ( click the link to review the publication )

J Control Release, 2018, 275:117-128

PubMed: 29474960 ( click the link to review the publication )

Haematologica, 2018, 103(4):679-687

PubMed: 29305415 ( click the link to review the publication )

J Hematol Oncol, 2018, 11(1):32

PubMed: 29486795 ( click the link to review the publication )

Cancer Lett, 2018, 432:121-131

PubMed: 29890207 ( click the link to review the publication )

Acta Biomater, 2018, 71:261-270

PubMed: 29526828 ( click the link to review the publication )
Sci Signal, 2018, 11(557)

PubMed: 30459282 ( click the link to review the publication )

J Exp Clin Cancer Res, 2018, 37(1):153

PubMed: 30012171 ( click the link to review the publication )

Mol Cancer Ther, 2018, 17(12):2767-2779

PubMed: 30232145 ( click the link to review the publication )

J Virol, 2018, 92(10)

PubMed: 29343578 ( click the link to review the publication )

J Virol, 2018, 92(6)

PubMed: 29298886 ( click the link to review the publication )

J Cell Mol Med, 2018, 22(5):2600-2611

PubMed: 29461008 ( click the link to review the publication )

Sci Rep, 2018, 8(1):3521

PubMed: 29476067 ( click the link to review the publication )

Front Microbiol, 2018, 9:2022

PubMed: 30283406 ( click the link to review the publication )

J Cell Biochem, 2018, 119(5):4193-4204

PubMed: 29274289 ( click the link to review the publication )

Retrovirology, 2018, 15(1):36

PubMed: 29751762 ( click the link to review the publication )

Exp Cell Res, 2018, 371(1):231-237

PubMed: 30107147 ( click the link to review the publication )

BMC Cancer, 2018, 18(1):466

PubMed: 29695239 ( click the link to review the publication )

Oncol Rep, 2018, 39(1):264-270

PubMed: 29115632 ( click the link to review the publication )

Ann Hematol, 2018, 97(5):839-849

PubMed: 29359239 ( click the link to review the publication )

Biochem Biophys Res Commun, 2018, 498(3):481-486

PubMed: 29505792 ( click the link to review the publication )

AAPS PharmSciTech, 2018, 19(2):634-647

PubMed: 28948528 ( click the link to review the publication )

Cell Biochem Funct, 2018, 36(8):398-407

PubMed: 30484863 ( click the link to review the publication )

Alcohol Clin Exp Res, 2018, 42(11):2160-2171

PubMed: 30103280 ( click the link to review the publication )

Sci Adv, 2018, 4(9):eaar4666

PubMed: 30263952 ( click the link to review the publication )

Nat Struct Mol Biol, 2017, 24(1):47-54

PubMed: 27870832 ( click the link to review the publication )

Clin Cancer Res, 2017, 23(12):3139-3149

PubMed: 27986747 ( click the link to review the publication )

Haematologica, 2017, 102(4):736-745

PubMed: 27979926 ( click the link to review the publication )

Clin Cancer Res, 2017, 23(12):3084-3096

PubMed: 27993968 ( click the link to review the publication )

Oncogene, 2017, 36(34):4859-4874

PubMed: 28414307 ( click the link to review the publication )
Oncogene, 2017, 36(12):1707-1720

PubMed: 27694895 ( click the link to review the publication )

Br J Pharmacol, 2017, 174(20):3608-3622

PubMed: 28749535 ( click the link to review the publication )

Eur J Med Chem, 2017, 127:531-553

PubMed: 28109947 ( click the link to review the publication )

Eur J Med Chem, 2017, 141:596-602

PubMed: 29102179 ( click the link to review the publication )

Cancer Sci, 2017, 108(7):1485-1492

PubMed: 28498513 ( click the link to review the publication )

Int J Mol Sci, 2017, 18(5)

PubMed: 28481295 ( click the link to review the publication )

J Biol Chem, 2017, 292(12):5043-5054

PubMed: 28167529 ( click the link to review the publication )

J Pharmacol Exp Ther, 2017, 363(2):211-220

PubMed: 28860353 ( click the link to review the publication )

Pharm Res, 2017, 34(3):668-679

PubMed: 28101809 ( click the link to review the publication )

Cancer Med, 2017, 6(11):2673-2685

PubMed: 29024573 ( click the link to review the publication )

Int J Cell Biol, 2017, 2017:6169310

PubMed: 28321257 ( click the link to review the publication )

Connect Tissue Res, 2017, 58(1):64-75

PubMed: 27404795 ( click the link to review the publication )

Pulm Pharmacol Ther, 2017, 44:88-95

PubMed: 28323055 ( click the link to review the publication )

Am J Surg, 2017, 213(4):645-651

PubMed: 28007318 ( click the link to review the publication )

Oncotarget, 2017, 8(28):45687-45697

PubMed: 28537899 ( click the link to review the publication )

Oncotarget, 2017, 9(1):512-523

PubMed: 29416632 ( click the link to review the publication )

Oncotarget, 2017, 8(31):51429-51446

PubMed: 28881658 ( click the link to review the publication )

CPT Pharmacometrics Syst Pharmacol, 2017, 6(11):756-764

PubMed: 29045072 ( click the link to review the publication )

Sci Rep, 2017, 7(1):2290

PubMed: 28536458 ( click the link to review the publication )

Oncotarget, 2017, 8(45):78480-78495

PubMed: 29108243 ( click the link to review the publication )

JCI Insight, 2017, 2(1):e85811

PubMed: 28097226 ( click the link to review the publication )

JCI Insight, 2017, 2(6):e90196

PubMed: 28352655 ( click the link to review the publication )

Oncotarget, 2017, 10.18632/oncotarget.15017

PubMed: 28157715 ( click the link to review the publication )

Oncotarget, 2017, 8(44):77254-77267

PubMed: 29100385 ( click the link to review the publication )
Cell Host Microbe, 2017, 21(5):569-579

PubMed: 28494238 ( click the link to review the publication )

Ann Oncol, 2016, 27(3):508-13

PubMed: 26658891 ( click the link to review the publication )

Nat Commun, 2016, 7:11363

PubMed: 27193833 ( click the link to review the publication )

Cancer Res, 2016, 76(23):7001-7011

PubMed: 27671680 ( click the link to review the publication )

Cancer Res, 2016, 76(8):2376-83

PubMed: 26941288 ( click the link to review the publication )

Int J Cancer, 2016, 139(1):194-204

PubMed: 26914605 ( click the link to review the publication )

Drug Discov Today, 2016, 21(9):1553-1560

PubMed: 27371506 ( click the link to review the publication )

mBio, 2016, 7(6)

PubMed: 27803184 ( click the link to review the publication )

J Med Chem, 2016, 59(4):1613-33

PubMed: 26681404 ( click the link to review the publication )

Mol Cancer Ther, 2016, 15(6):1364-75

PubMed: 27196750 ( click the link to review the publication )

Mol Cell Proteomics, 2016, 15(6):2076-92

PubMed: 27067055 ( click the link to review the publication )

Neuropharmacology, 2016, 107:111-121

PubMed: 26970016 ( click the link to review the publication )

Biochem Pharmacol, 2016, 102:130-140

PubMed: 26718586 ( click the link to review the publication )

Sci Rep, 2016, 6:38219

PubMed: 27910887 ( click the link to review the publication )

Am J Pathol, 2016, 186(10):2701-8

PubMed: 27555113 ( click the link to review the publication )

J Biol Chem, 2016, 291(19):10131-47

PubMed: 27022024 ( click the link to review the publication )

Neurochem Int, 2016, 96:24-31

PubMed: 27103167 ( click the link to review the publication )

Int J Oncol, 2016, 49(6):2453-2463

PubMed: 27748897 ( click the link to review the publication )

Am J Physiol Heart Circ Physiol, 2016, 311(5):H1139-H1149

PubMed: 27638876 ( click the link to review the publication )

Cancer Biol Ther, 2016, 17(1):27-35

PubMed: 26575826 ( click the link to review the publication )

Anal Bioanal Chem, 2016, 408(13):3547-53

PubMed: 26968571 ( click the link to review the publication )

BMC Cancer, 2016, 16:667

PubMed: 27549189 ( click the link to review the publication )

J Hum Genet, 2016, 10.1038/jhg.2016.61

PubMed: 27251006 ( click the link to review the publication )

Med Oncol, 2016, 33(2):11

PubMed: 26732474 ( click the link to review the publication )
Inflammation, 2016, 39(1):39-46

PubMed: 26228975 ( click the link to review the publication )

PLoS One, 2016, 11(8):e0160826

PubMed: 27536989 ( click the link to review the publication )

PLoS One, 2016, 11(1):e0145985

PubMed: 26726879 ( click the link to review the publication )

Onco Targets Ther, 2016, 9:6843-6855

PubMed: 27877053 ( click the link to review the publication )

Leuk Lymphoma, 2016, 57(3):692-9

PubMed: 26084206 ( click the link to review the publication )

Asian Pac J Trop Med, 2016, 9(6):572-6

PubMed: 27262069 ( click the link to review the publication )

Genet Mol Res, 2016, 15(4)

PubMed: 27819724 ( click the link to review the publication )

Oncotarget, 2016, 8(62):104733-104744

PubMed: 29285209 ( click the link to review the publication )

Oncotarget, 2016, 7(36):58142-58147

PubMed: 27494885 ( click the link to review the publication )

Sci Rep, 2016, 6:21678

PubMed: 26902929 ( click the link to review the publication )

Oncotarget, 2016, 7(6):6727-47

PubMed: 26734995 ( click the link to review the publication )

Nat Commun, 2015, 6:7888

PubMed: 26223951 ( click the link to review the publication )

Nat Commun, 2015, 3;6:10091

PubMed: 26631872 ( click the link to review the publication )

EMBO Mol Med, 2015, 10.15252/emmm.201404396

PubMed: 25872941 ( click the link to review the publication )

EMBO Mol Med, 2015, 10.15252/emmm.201404580

PubMed: 25759362 ( click the link to review the publication )

Clin Cancer Res, 2015, 10.1158/1078-0432.CCR-14-2701

PubMed: 25813020 ( click the link to review the publication )

Clin Cancer Res, 2015, 21(7):1628-38

PubMed: 25623213 ( click the link to review the publication )

Blood Cancer J, 2015, 5:e312

PubMed: 25978432 ( click the link to review the publication )

Int J Cancer, 2015, 136(11):2717-29

PubMed: ( click the link to review the publication )

EBioMedicine, 2015, 3:108-121

PubMed: 26870822 ( click the link to review the publication )

Cancer Lett, 2015, 356(2 Pt B):828-36

PubMed: 25449774 ( click the link to review the publication )

Cancer Lett, 2015, 366(1):32-43

PubMed: 26028172 ( click the link to review the publication )

Breast Cancer Res, 2015, 17:33

PubMed: 25888415 ( click the link to review the publication )

Cell Death Dis, 2015, 6:e1657

PubMed: 25695609 ( click the link to review the publication )
Acta Neuropathol Commun, 2015, 3(1):22

PubMed: 25853389 ( click the link to review the publication )

Endocr Relat Cancer, 2015, 22(5):777-92

PubMed: 26206775 ( click the link to review the publication )

Br J Haematol, 2015, 168(3):371-83

PubMed: ( click the link to review the publication )

Epigenetics, 2015, 10.1080/15592294.2015.1039216

PubMed: 25923331 ( click the link to review the publication )

Am J Cancer Res, 2015, 5(4):1337-52

PubMed: 26101701 ( click the link to review the publication )

Neuropharmacology, 2015, 99:67-78

PubMed: 26188143 ( click the link to review the publication )

Biochemical Pharmacology, 2015, 94(2):79-90

PubMed: ( click the link to review the publication )

Biochem Pharmacol, 2015, 94(2):79-90

PubMed: 25600908 ( click the link to review the publication )

Biochemical Pharmacology, 2015, 94(2):79-90

PubMed: ( click the link to review the publication )

Apoptosis, 2015, 20(7):975-85

PubMed: 25835755 ( click the link to review the publication )

J Biol Chem, 2015, 290(8):5028-40

PubMed: 25540204 ( click the link to review the publication )

J Biol Chem, 2015, 290(39):23725-37

PubMed: 26269591 ( click the link to review the publication )

J Biol Chem, 2015, 290(3):1829-36

PubMed: 25492871 ( click the link to review the publication )

J Biol Chem, 2015, 290(8):5028-40

PubMed: ( click the link to review the publication )

BMC Cancer, 2015, 15(1):273

PubMed: 25880212 ( click the link to review the publication )

FEBS Lett, 2015, 589(10):1080-8

PubMed: 25816750 ( click the link to review the publication )

J Biotechnol, 2015, 10.1016/j.jbiotec.2015.02.029

PubMed: 25746901 ( click the link to review the publication )

Mol Vis, 2015, 21:502-14

PubMed: 25999677 ( click the link to review the publication )

Mol Med Rep, 2015, 12(3):4291-4297

PubMed: 26095064 ( click the link to review the publication )

Oncotarget, 2015, 6(18):15814-27

PubMed: 26158412 ( click the link to review the publication )

Circ Heart Fail, 2015, 8(6):1094-104

PubMed: 26371176 ( click the link to review the publication )

Sci Transl Med, 2014, 6(256):256ra135

PubMed: 25273096 ( click the link to review the publication )

Acta Neuropathol, 2014, 128(2):291-303

PubMed: 24839957 ( click the link to review the publication )

Nat Commun, 2014, 5:3361

PubMed: 24553445 ( click the link to review the publication )
Clin Cancer Res, 2014, 10.1158/1078-0432.CCR-14-0384

PubMed: 25355930 ( click the link to review the publication )

Int J Cancer, 2014, 135(7):1721-32

PubMed: 24615207 ( click the link to review the publication )

Diabetes, 2014, 63(9):2924-34

PubMed: 24722245 ( click the link to review the publication )

Oncogene, 2014, 33(25):3307-15

PubMed: 23995789 ( click the link to review the publication )

Cancer Lett, 2014, 10.1016/j.canlet.2014.10.034

PubMed: ( click the link to review the publication )

Cancer Lett, 2014, 351(1):50-8

PubMed: 24814395 ( click the link to review the publication )

PLoS Pathog, 2014, 10(4):e1004071

PubMed: 24722454 ( click the link to review the publication )

Cell Death Dis, 2014, 5:e1134

PubMed: 24651437 ( click the link to review the publication )

Cell Death Dis, 2014, 5:e1177

PubMed: 24743732 ( click the link to review the publication )

Mol Cancer Ther, 2014, 13(12):2784-92

PubMed: 25319394 ( click the link to review the publication )

J Mol Biol, 2014, 426(20):3442-53

PubMed: 24657767 ( click the link to review the publication )

Hum Gene Ther, 2014, 25(7):599-608

PubMed: 24568341 ( click the link to review the publication )

J Biol Chem, 2014, 289(14):9918-25

PubMed: 24515107 ( click the link to review the publication )

Cancer Cell Int, 2014, 10.1186/s12935-014-0112-x

PubMed: ( click the link to review the publication )

Cancer Cell Int, 2014, 14(1):112

PubMed: 25546354 ( click the link to review the publication )

Mol Cell Biol, 2014, 34(7):1280-9

PubMed: 24469401 ( click the link to review the publication )

Proteomics Clin Appl, 2014, 8(11-12):924-31

PubMed: 25091122 ( click the link to review the publication )

J Alzheimers Dis, 2014, 41(4):1193-205

PubMed: 24844691 ( click the link to review the publication )

Virology, 2014, 462-463:328-39

PubMed: 25014309 ( click the link to review the publication )

Cancer Biol Ther, 2014, 15(5):578-85

PubMed: 24556916 ( click the link to review the publication )

BMC Cancer, 2014, 14(1):373

PubMed: 24886166 ( click the link to review the publication )

FEBS Lett, 2014, 588(9):1571-9

PubMed: 24607544 ( click the link to review the publication )

Mol Med Rep, 2014, 10(5):2729-35

PubMed: 25199623 ( click the link to review the publication )

Oncol Lett, 2014, 7(5):1673-1678

PubMed: 24765199 ( click the link to review the publication )
Pharmacol Res Perspect, 2014, 2(3):e00043

PubMed: 25505589 ( click the link to review the publication )

Head Neck, 2014, 10.1002/hed.23822.

PubMed: 24986420 ( click the link to review the publication )

Cytometry A, 2014, 85(1):78-87

PubMed: 24038859 ( click the link to review the publication )

Curr Pharm Desigh, 2014, 20(11):1874-80

PubMed: 23888956 ( click the link to review the publication )

Pharmacology Research Perspectives, 2014, 10.1002/prp2.43

PubMed: ( click the link to review the publication )

Oncotarget, 2014, 5(15):5965-77

PubMed: 25115389 ( click the link to review the publication )

Blood, 2013, 14;121(11):2038-50

PubMed: 23327920 ( click the link to review the publication )

Blood, 2013, 123(5):706-16

PubMed: 24319254 ( click the link to review the publication )

Nat Struct Mol Biol, 2013, 20(3):317-25

PubMed: 23377543 ( click the link to review the publication )

Proc Natl Acad Sci USA, 2013, 111(3):E364-73

PubMed: 24395801 ( click the link to review the publication )

PLoS Biol, 2013, 12(1):e1001758

PubMed: 24409098 ( click the link to review the publication )

Cancer Res, 2013, 73(8):2428-34

PubMed: 23382048 ( click the link to review the publication )

Cell Rep, 2013, 5(6):1679-89

PubMed: 24360956 ( click the link to review the publication )

Int J Cancer, 2013, 132(9):2200-8

PubMed: 23024001 ( click the link to review the publication )

Neuropsychopharmacology, 2013, 38(9):1674-84

PubMed: 23474591 ( click the link to review the publication )

Oncogene, 2013, 33(33):4265-72

PubMed: 24292675 ( click the link to review the publication )

Oncogene, 2013, 32(10):1316-29

PubMed: 22543582 ( click the link to review the publication )

Cell Death Dis, 2013, 4:e733

PubMed: 23868066 ( click the link to review the publication )

Cell Death Dis, 2013, 4:e951

PubMed: 24309938 ( click the link to review the publication )

Br J Haematol, 2013, 160(2):188-98

PubMed: 23167276 ( click the link to review the publication )

AIDS, 2013, 27(18):2853-62

PubMed: 24189584 ( click the link to review the publication )

J Biol Chem, 2013, 288(35):25593-602

PubMed: 23878197 ( click the link to review the publication )

J Biol Chem, 2013, 288(20):14400-7

PubMed: 23539624 ( click the link to review the publication )

PLoS Comput Biol, 2013, 9(2):e1002887

PubMed: 23408876 ( click the link to review the publication )
Mol Carcinog, 2013, 52(3):218-28

PubMed: 22121107 ( click the link to review the publication )

Front Pharmacol, 2013, 4:44

PubMed: 23596417 ( click the link to review the publication )

Genes Brain Behav, 2013, 13(1):69-86

PubMed: 24286462 ( click the link to review the publication )

Cell Cycle, 2013, 12(13):2073-83

PubMed: 23759592 ( click the link to review the publication )

PLoS One, 2013, 8(6):e66130

PubMed: 23762475 ( click the link to review the publication )

PLoS One, 2013, 8(1):e53766

PubMed: 23320102 ( click the link to review the publication )

J Thromb Thrombolysis, 2013, 35(2):185-92

PubMed: 23229086 ( click the link to review the publication )

Cell Death Dis, 2013, 4:e655

PubMed: 23744355 ( click the link to review the publication )

Blood, 2012, 8;120(19):3958-67

PubMed: 22983447 ( click the link to review the publication )

J Exp Med, 2012, 209(1):35-50

PubMed: 22231305 ( click the link to review the publication )

Clin Cancer Res, 2012, 18(14):3822-33

PubMed: 22623731 ( click the link to review the publication )

Clin Cancer Res, 2012, 18(2):408-16

PubMed: 22038994 ( click the link to review the publication )

Cancer Res, 2012, 72(9):2251-61

PubMed: 22422937 ( click the link to review the publication )

Cell Death Differ, 2012, 19(12):2029-39

PubMed: 22858545 ( click the link to review the publication )

Cell Death Differ, 2012, 19(8):1317-27

PubMed: 22322857 ( click the link to review the publication )

Eur J Cancer, 2012, 48(7):1096-107

PubMed: 22154545 ( click the link to review the publication )

Diabetologia, 2012, 55(9):2421-31

PubMed: 22772764 ( click the link to review the publication )

FASEB J, 2012, 26(7):3032-41

PubMed: 22459148 ( click the link to review the publication )

J Neurochem, 2012, 123 Suppl 2:108-15

PubMed: 23050648 ( click the link to review the publication )

J Leukoc Biol, 2012, 91(5):701-9

PubMed: 22028329 ( click the link to review the publication )

J Biol Chem, 2012, 287(43):36609

PubMed: 22952229 ( click the link to review the publication )

Mol Carcinog, 2012, 52(6):459-74

PubMed: 22308110 ( click the link to review the publication )

Invest New Drugs, 2012, 30(2):541-7

PubMed: 21107885 ( click the link to review the publication )

Pharm Res, 2012, 29(7):1960-76

PubMed: 22415140 ( click the link to review the publication )
Oncol Rep, 2012, 28(1):105-10

PubMed: 22484732 ( click the link to review the publication )

PLoS One, 2012, 7(9):e44265

PubMed: 22957056 ( click the link to review the publication )

PLoS One, 2012, 7(12):e52335

PubMed: 23272238 ( click the link to review the publication )

PLoS One, 2012, 7(12):e52753

PubMed: 23300762 ( click the link to review the publication )

Chronobiol Int, 2012, 29(8):982-93

PubMed: 22891617 ( click the link to review the publication )

Biochem Biophys Res Co, 2012, 420(2):325-30

PubMed: 22425986 ( click the link to review the publication )

Pediatr Surg Int, 2012, 28(6):579-89

PubMed: 22526548 ( click the link to review the publication )

Protein Expr Purif, 2012, 86(1):45-52

PubMed: 21992606 ( click the link to review the publication )

Brain, 2011, 134(Pt 8):2408-21

PubMed: 21772061 ( click the link to review the publication )

Clin Cancer Res, 2011, 17(9):2819-29

PubMed: 21357681 ( click the link to review the publication )

Clin Cancer Res, 2011, 17(16):5311-21

PubMed: 21724551 ( click the link to review the publication )

Genes Dev, 2011, 25(24):2610-8

PubMed: 22016339 ( click the link to review the publication )

J Neurosci, 2011, 31(11):3990-9

PubMed: 21411642 ( click the link to review the publication )

J Transl Med, 2011, 9:37

PubMed: 21477288 ( click the link to review the publication )

Retrovirology, 2011, 2(3):411-23

PubMed: 21966324 ( click the link to review the publication )

Mol Med, 2011, 17(5-6):466-72

PubMed: 21424110 ( click the link to review the publication )

PLoS One, 2011, 6(7):e22739

PubMed: 21818379 ( click the link to review the publication )

BMC Neurosci, 2011, 12:50

PubMed: 21615950 ( click the link to review the publication )

Sci Signal, 2010, 3(146):ra80

PubMed: 21045206 ( click the link to review the publication )

J Pharmacol Exp Ther, 2010, 86(16):8765-72

PubMed: 20739454 ( click the link to review the publication )

Exp Dermatol, 2010, 19(12):1096-102

PubMed: 20629733 ( click the link to review the publication )

产品安全说明书

HDAC抑制剂选择性比较

生物活性

产品描述

Vorinostat (suberoylanilide hydroxamic acid, SAHA)是一种HDAC抑制剂，无细胞试验中IC50为~10 nM。Vorinostat 会抑制高效的HPV-18 DNA扩增。

特性

Vorinostat是广谱HDAC活性抑制剂，抑制I和II类酶。

靶点

HDAC ^[1]
(Cell-free assay)

~10 nM

体外研究

Vorinostat是小分子量（<300）线性肟酸，抑制HDAC活性，包括乙酰化组蛋白和非组蛋白的积累，抑制培养细胞的增殖，且抑制肿瘤生长。Vorinostat通过结合到酶的活性位点而抑制 HDAC活性。Vorinostat 抑制多种转化细胞增殖（包括淋巴瘤，多发性骨髓瘤，白血病，和非小细胞肺癌），与对照组相比抑制生长达50% 时的浓度为0.5 到10μM。Vorinostat作用于淋巴瘤和白血病细胞，包括 Burkitt, B-细胞急性淋巴细胞白血病 (B-ALL), MCL, DLBCL, ATL和T-细胞，不同程度抑制细胞增殖。除了抑制转化细胞增殖, Vorinostat 也抑制正常细胞增殖，通过比较Vorinostat 作用于一组细胞系–正常人非纤维细胞(WI-38)和 SV40巨大T抗原转化WI-38(VA-13细胞)而得到证明。Vorinostat 抑制两种类型细胞增殖，这种作用存在剂量依赖性。但发现Vorinostat 对转化细胞具有选择毒性，包括使肿瘤细胞死亡，而对正常细胞只起抑制作用，不会使其死亡。^[1] Genistein 和Vorinostat 联用效果比5-aza和Vorinostat 联用作用于诱导细胞死亡有效很多。Genistein和Vorinostat联用作用于ARCaP-E使增殖降低 80 %，作用于ARCaP-M细胞，增殖降低60 %以上。Genistein和Vorinostat 联用抑制细胞增殖具有协同效应。作用于ARCaP-E 细胞(820个基因诱导和1046个基因抑制) ARCaP-M 细胞，Vorinostat比Genistein 影响更多基因。^[2] Vorinostat作用于肿瘤细胞表面，提高Fas蛋白水平，这种作用存在剂量依赖性，且按0.75 μM剂量处理，提高达到一个稳定水平。^[3] Vorinostat 抑制肿瘤细胞生长，包括NB4, H460 和HCT-116，IC50分别为0.7μM, 3.4μM和1.2 μM。^[4]

Cell Data

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID
A20	M2nKNWtqdmG\|ZTDBd5NigQ>?		MlryNUBp	NWrLOYE5TE2VTx?=	NFzj[nNidnSrLVjERWMyKGGldHn2bZR6KHerdHigTWM2OCCxZjCwMlEyOiEQvF2=	NFXBfpYyOTl4MES4PS=>
Friend leukemic cell	NXq1TXhzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MUi1NEDPxE1?	MWq3NkBp	MnjqSG1UVw>?	NVi3dWNPUUN3ME2wMlk6KM7:TR?=	MlnWNVIyODl7MUO=
K562	NW\nPYJZU2mwYYPlJGF{e2G7		NGPiWW43KGh?	NYnQe\|FOTE2VTx?=	NYj3NGJWUW6qaXLpeIlwdiCxZjDoeY1idiCqaYP0c45mKGSnYXPleJlt[XOnIDjtbZh1fXKnIH;mJGhFSUNzIHHu[EBJTEGFMjmge4l1cCCLQ{WwJI9nKDBwMEGg{txO	M{O0Z\|EzPDF7M{iw
HT1080	Mnz2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M4jkOFczKGh?	MXzEUXNQ	M{H5dWlEPTB;Mj60JO69VQ>?	MkfGNVIzPzBzN{W=
H1299	NFPFVGRMcW6jc3WgRZN{[Xl?		NXLpeWs2OjBibXnu	Mn\FSG1UVw>?	NEjvRYdKdmirYnn0c5J6KGGldHn2bZR6KGGpYXnud5QhUESDQzDlcpp6dWVid3n0bEBKSzVyIH;mJFAvOTl2IN88US=>	MkjONVQ2OjF2MkK=
H1299	MnLMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NVzy[m1uPzJiaB?=	NHvWcFFFVVOR	MUHJR\|UxRTdwMkSg{txO	NYnXOVVtOTR3MkG0NlI>
HeLa	M2XNemtqdmG\|ZTDBd5NigQ>?		MW[zNEBucW5?		NYDCc\|VbUW6qaXLpeI9zgSClb37j[Y51emG2aX;uJIFo[Wmwc4SgbIl{fG:wZTDk[YFk\XS7bHHz[UB4cXSqIFnDOVAhd2ZiMD6yPEDPxE1?	MorFNVU3ODN7NEm=
LOX-IMVI	MnLRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M2DRVFQ5KGh?		NGPTd49KSzVyPUGuN{DPxE1?	MlnONVU4OTV2N{C=
NCI-H226	NGPIZlJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NEGwfo41QCCq		NHrG[3ZKSzVyPUKuOkDPxE1?	MVuxOVcyPTR5MB?=
RXF-631L	NUDVOXplT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MYq0PEBp		NGjhW2xKSzVyPUKg{txO	NUW3XJZoOTV5MUW0O\|A>
SNB-78	NYS0OINST3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NYPrTFl4PDhiaB?=		Mk\RTWM2OD1zNjFOwG0>	Mn\UNVU4OTV2N{C=
St-4	MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		Mki5OFghcA>?		M4DlNGlEPTB;NT6yJO69VQ>?	MWWxOVcyPTR5MB?=
ARP1	NXfKe\|dsTnWwY4Tpc44hSXO\|YYm=	M3ToN\|Ih\|ryP	NIOyfVk3KGh?		NYXOWmJRUW6mdXP0bY9vKG:oIGCyNXdCTjFiZ3Xu[UBmgHC{ZYPzbY9v	MmjjNVQ4OzR6ME[=
CEM	NVrBN4JLU2mwYYPlJGF{e2G7		NG\k[IEyKGh?	MnzsSG1UVw>?	M4nzbmlvcGmkaYTpc44hd2ZiSFTBR{B4cXSqIFnDOVAhd2ZiMD6zN{DPxE1?	MlfsNVY1OjByNkS=
HCT15	MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M3i4Z\|Q5KGh?		Mo\IS2k2OD1yLkiyJO69VQ>?	MofPNVY4OjN{Mke=
NCI-H23	M3\ISGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MmDTOFghcA>?		Ml7CS2k2OD1yLkmyJO69VQ>?	Mnu0NVY4OjN{Mke=
GM15850	Ml3sT4lv[XOnIFHzd4F6	NGn3V\|QzNjVizszN	NFPZclA6PiCq	NFu1RXFFVVOR	NFvPVXRKdmirYnn0bY9vKG:oIFjERWMh[XO\|ZYPz[YQh[XNiaX7jdoVie2ViaX6gbIl{fG:wZTDIN{BtgXOrbnWgNVQh[WOndInsZZRqd25ib3[gSnhPKGenbnW=	NH3obmMyPjl{MUO2Oy=>
GM15850	NHjx[XZMcW6jc3WgRZN{[Xl?	MV6yMlUh\|ryP	MWq5OkBp	NG\vWIRFVVOR	NVL6TJVSUW6qaXLpeIlwdiCxZjDISGFEKGG\|c3Xzd4VlKGG\|IHnuZ5Jm[XOnIHnuJIhqe3SxbnWgTFQhdHm\|aX7lJFUh[WOndInsZZRqd25ib3[gSnhPKGenbnW=	NGj5c4EyPjl{MUO2Oy=>
GM15850	M1rKSmtqdmG\|ZTDBd5NigQ>?	Mln4Nk42KM7:TR?=	NELoelA6PiCq	M4jYNmROW09?	M2XJbWlvcGmkaYTpc44hd2ZiSFTBR{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDobZN1d26nIFi0JIx6e2mwZTCxNkBi[2W2eXzheIlwdiCxZjDGXG4h\2WwZR?=	NXvM[IZjOTZ7MkGzOlc>
GM15850	MVTLbY5ie2ViQYPzZZk>	M4j1fFIvPSEQvF2=	MXK5OkBp	NYDjelFYTE2VTx?=	MXPJcohq[mm2aX;uJI9nKEiGQVOgZZN{\XO\|ZXSgZZMhcW6lcnXhd4UhcW5iaHnzeI9v\SCKMzDsfZNqdmViOTDhZ4V1gWyjdHnvckBw\iCIWF6g[4Vv\Q>?	MnrSNVY6OjF\|Nke=
GM15850	M3npfmtqdmG\|ZTDBd5NigQ>?	NHvpbWIzNjVizszN	M4j1[lk3KGh?	M3fTR2ROW09?	NWTuRWNuUW6qaXLpeIlwdiCxZjDISGFEKGG\|c3Xzd4VlKGG\|IHnuZ5Jm[XOnIHnuJIhqe3SxbnWgTFQhdHm\|aX7lJFgh[WOndInsZZRqd25ib3[gSnhPKGenbnW=	NHT3eosyPjl{MUO2Oy=>
GM15850	M4P3ZmtqdmG\|ZTDBd5NigQ>?	M3fnUlIvPSEQvF2=	M1zwPVk3KGh?	NFzpfVBFVVOR	MYLJcohq[mm2aX;uJI9nKEiGQVOgZZN{\XO\|ZXSgZZMhcW6lcnXhd4UhcW5iaHnzeI9v\SCKNDDsfZNqdmViMU[gZYNmfHmuYYTpc44hd2ZiRmjOJIdmdmV?	M3LlO\|E3QTJzM{[3
U937	NWHyfXZkTnWwY4Tpc44hSXO\|YYm=	M3LNbFUh\|ryP	M3jSOlI1KGh?	NF\WOGdFVVOR	NU\JbHNyS2WubDDjfYNt\SCjcoLld5Qh[nliYXPjeY12dGG2aX;uJIF1KFNxR{KvUUBxcGG\|ZR?=	MVuxO\|AxPDdzOB?=
H661	MoX5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MlHJOFghcA>?		MXLJR\|UxRTFizszN	MlraNVcyPTdyMEm=
U937	M3XKOWZ2dmO2aX;uJGF{e2G7	MVi1JO69VQ>?	NEnEV4ozPCCq	MXHEUXNQ	MnrGTY5kemWjc3WgbY4hcGm\|dH;u[UBJOyCjY3X0fYxifGmxbh?=	MYOxO\|Q1Pzd3MB?=
U937	NF7zPWhHfW6ldHnvckBCe3OjeR?=	MVWxJO69VQ>?	M2DZ[VI1KGh?	NYnsN4ViTE2VTx?=	NHTEfmJG\m[nY4Sgc44h[WyyaHGgeJVjfWyrbjDhZ4V1gWyjdHnvci=>	NGDWW3AyPzR2N{e1NC=>
RAW264.7	MVPGeY5kfGmxbjDBd5NigQ>?	MoDFNVAh\|ryP	M37BTlI1cA>?	MV;3ZZRmeg>?	MV7Jcohq[mm2aX;uJI9nKEySUz3zeIlufWyjdHXkJHRPTmGucHjhJJBzd2S3Y4Tpc44hf2m2aDDJR\|UxKG:oIECuO\|Yh\|ryP	M4H3TVE4PDd5NUG4
RAW264.7	MnSwSpVv[3Srb36gRZN{[Xl?	MoP0NVAh\|ryP	MkTBNlRp	NYXlUJFUf2G2ZYK=	NELWcZFKdmirYnn0bY9vKG:oIFzQV{1{fGmvdXzheIVlKE6RIIDyc4R2[3Srb36ge4l1cCCLQ{WwJI9nKDFwOEig{txO	NVnuPIlJOTd2N{e1NVg>
SC9	NHriN5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NX3aN2lnPDhiaB?=		NVzUUYxXUUN3ME2wMlYxPiEQvF2=	NFXOVIEyPzVyN{KxPS=>
ST14A	M3\1bWZ2dmO2aX;uJGF{e2G7	NX7RWnA{PSCwTR?=	NES4[4o4OiCq		MWfJcoNz\WG\|ZTDpckBTTVOWL17SV2YhdVKQQTDlfJBz\XO\|aX;u	M1vLfVE4PTZ3OUmz
ST14A	NI\iTYRHfW6ldHnvckBCe3OjeR?=	M2[zTlUhdk1?	Mlq3O\|IhcA>?		M1vR[2lv[3KnYYPlJIlvKEV{RkGgcXJPSSCneIDy[ZN{cW:w	M{fsS\|E4PTZ3OUmz
PANC1	Ml7aS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MVOxJO69VQ>?			MX7JR\|UxRTBwNEWg{txO	Mn61NVc2QDh5NES=
PANC1	NF;ieVdHfW6ldHnvckBCe3OjeR?=	MYGxJO69VQ>?	MmHVNlQhcA>?		MmLpTY5kemWjc3WgbY4heDJzV1HGNU9EUVBzIHflcoUh\XiycnXzd4lwdg>?	M{TIUFE4PTh6N{S0
PANC1	NX;yU4hjTnWwY4Tpc44hSXO\|YYm=	NGnNN\|UyKM7:TR?=	MUSyOEBp		Mnz6TY5kemWjc3WgbY4heDJ5a3nwNUBo\W6nIHX4dJJme3Orb36=	NX3hXVFoOTd3OEi3OFQ>
PT45	NX7XV\|k{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Mm\WTWM2OD12IN88US=>	MWKxO\|U5QDd2NB?=
ACHN	M4HldGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		NIfjSVEzOSCq		NVTpb4NHT0l3ME2wMlY2KM7:TR?=	MV2xO\|Y3OjZyNh?=
PC3	NV;nNJhHT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M1TWTFIyKGh?		MmXkS2k2OD1yLkexJO69VQ>?	NHzKSZIyPzZ4Mk[wOi=>
A431	MULDfZRwfG:6aXOgRZN{[Xl?		MY[3NkBp		MnL6TWM2OD12LkKg{txO	NF;zXoQyPzZ7MUe2Ny=>
Cal27	NWnielNPS3m2b4TvfIlkKEG\|c3H5		MoXqO\|IhcA>?		M{P3UmlEPTB;Mz6yJO69VQ>?	NEHx[IYyPzZ7MUe2Ny=>
CCRF-CEM	MmXmR5l1d3SxeHnjJGF{e2G7		MoTzO\|IhcA>?		NVPvPGQxUUN3ME2wMlgh\|ryP	NHPTNYYyPzZ7MUe2Ny=>
EOL1	NUK0XFFZS3m2b4TvfIlkKEG\|c3H5		NUXQNo9UPzJiaB?=		NYHyeZBFUUN3ME2xJO69VQ>?	NFzwd3YyPzZ7MUe2Ny=>
Hec-1-A	NYn3T5Z{S3m2b4TvfIlkKEG\|c3H5		MonpO\|IhcA>?		NUK4R3Y2UUN3ME2xJO69VQ>?	M3SzPFE4PjlzN{[z
HeLa	NX3PTYxbU2mwYYPlJGF{e2G7	M1nLXlExKM7:TR?=	MoHmN\|AhdWmw	NEXTXXhFVVOR	MULJcohq[mm2aX;uJI9nKHKnY3;tZolv[W62IFjERWMyKHerdHigTWM2OCCxZjCwMlAzKM7:TR?=	MVmxO\|Y6OTd4Mx?=
RKOp21	MXnDfZRwfG:6aXOgRZN{[Xl?		NV\CPYtKPzJiaB?=		M4T0N2lEPTB;MT63OkDPxE1?	NUX6UnFnOTd4OUG3OlM>
Saos2	MWrDfZRwfG:6aXOgRZN{[Xl?		NFixcmQ4OiCq		M2\EWmlEPTB;Mj6zJO69VQ>?	M1LsblE4PjlzN{[z
SK-OV-3	NYfkO3Y5S3m2b4TvfIlkKEG\|c3H5		MYC3NkBp		MkfXTWM2OD1{LkKg{txO	MWqxO\|Y6OTd4Mx?=
U87MG	NIXyZ\|NEgXSxdH;4bYMhSXO\|YYm=		NVHFOpBTPzJiaB?=		MnKxTWM2OD1zMTFOwG0>	NWqybVdFOTd4OUG3OlM>
NUGC3	M1zqeWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NVSwdldEPSEQvF2=	MmrNNlQhcA>?		M374WmdKPTB;Mj63PUDPxE1?	MWmxO\|kxPDh2Mx?=
CCD1059SK	MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M1TUWGlEPTB;NEOuOUDPxE1?	MnnRNVgzPDd3NUS=
HepG2	NFrsW4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXW4WoxMUUN3ME2wMlAxODZizszN	Ml34NVgzPDd3NUS=
HT1080	NH70bXpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFvYNZlKSzVyPUCuNFAzPCEQvF2=	MorRNVgzPDd3NUS=
SKBR3	Ml[2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3SySGlEPTB;MD64JO69VQ>?	M1rlU\|E5OjR5NUW0
SNB78	NX;LdZB7T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NVnONY1GTUN3ME2xOkDPxE1?	NX2zd5VPOTh{NEe1OVQ>
SQ20B	NELUOY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M{PqZmlEPTB;MzFOwG0>	NWnFXFduOTh{NEe1OVQ>
St4	MnzZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MV;FR\|UxRTVwMjFOwG0>	NFvSSVYyQDJ2N{W1OC=>
MCF7	MX7GeY5kfGmxbjDBd5NigQ>?	MlmzNVAh\|ryP	M363O\|ghcA>?	M1P0b2ROW09?	NYS5Z2VUUW6mdXP0bY9vKG:oIIT1ZpVtcW5iaInw[ZJi[2W2eXzheIlwdg>?	NHSyNpgyQDJ4OUKyOi=>
HEK293	NXjjb4NOU2mwYYPlJGF{e2G7		NX;EUXRoOSCq	M{\pOGROW09?	NFvPZm1KdmirYnn0bY9vKG:oIFjERWMyKHerdHigTWM2OCCxZjCwMlA{KM7:TR?=	MYKxPFMxQDV4Mx?=
HEK293	NIPaPFhMcW6jc3WgRZN{[Xl?		MmnZNUBp	NGXCW\|lFVVOR	NX3LNWpVUW6qaXLpeIlwdiCxZjDISGFEOyC5aYToJGlEPTBib3[gNE4xPTdizszN	Mmj3NVg{ODh3NkO=
G401	MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NYjIWmpxPzJiaB?=	Mke5SG1UVw>?	M2XWUmlEPTB;MTFOwG0>	M3r1SFE5OzdyM{ez
HeLa	MnrNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		MWq3NkBp	MlLYSG1UVw>?	NGjROmJKSzVyPUCuOFYh\|ryP	NHLtWYwyQDN5MEO3Ny=>
Human renal epithelial cell	NFfKR3lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M{TtbVczKGh?	M{Dtd2ROW09?	M2nzdmlEPTB;MUSg{txO	NVvQPHhLOTh\|N{CzO\|M>
U937	Mo\TSpVv[3Srb36gRZN{[Xl?	NFvsWlc2KM7:TR?=	M1;qUVI1KGh?		M{PENmlv\HWldHnvckBw\iCqaYP0c45mKEh2IHj5dIVz[WOndInsZZRqd25?	NXP0cHNROTh\|OEGyN\|g>
U937	MV7GeY5kfGmxbjDBd5NigQ>?	MlXpOUDPxE1?	MnHWNlQhcA>?		MnH6TY5lfWO2aX;uJI9nKGGucHjhJJR2[nWuaX6gbJlx\XKjY3X0fYxifGmxbh?=	MV2xPFM5OTJ\|OB?=
U937	MkTxSpVv[3Srb36gRZN{[Xl?	NYfZPXlKPSEQvF2=	NHHBdVgzPCCq		NVfjSGFMUW6mdXP0bY9vKG:oIICyNUBmgHC{ZYPzbY9v	Mk\KNVg{QDF{M{i=
U937	NVnsTW5lTnWwY4Tpc44hSXO\|YYm=	MW[1JO69VQ>?	NFLseHAzPCCq		M1u3OWlv\HWldHnvckBw\iCjcH;weI9{cXN?	MmjBNVg{QDF{M{i=
U937	M3exO2Z2dmO2aX;uJGF{e2G7	MonuOUDPxE1?	NVTCc5dnOjRiaB?=		NFT1VXVKdmS3Y4Tpc44hd2ZiZ4LhcpVtd2O7dHnjJIRq\m[ncnXueIlifGmxbh?=	M17PbFE5OzhzMkO4
U937	NWD6[453U2mwYYPlJGF{e2G7	MXm1JO69VQ>?	NYm3OJRYOjRiaB?=		MYPJcohq[mm2aX;uJI9nKGi3bXHuJGhFSUNz	NXHEfodTOTh\|OEGyN\|g>
U937	NU\nbpd1U2mwYYPlJGF{e2G7	NUm5WWE4PSEQvF2=	NIf6TYMzPCCq		MV\Jcohq[mm2aX;uJI9nKGi3bXHuJGhFSUN2	NW\1[GVXOTh\|OEGyN\|g>
HEK-TE	NFL0TmxHfW6ldHnvckBCe3OjeR?=	NXHRcIhtPSEQvF2=	MWC2bC=>	NF\IWFhFVVOR	M2T3Wmlv[3KnYYPlJIlvKGirc4TvcoUhUDNiYXPleJlt[XSrb36=	M4W5TlE5PDN2MUS0
HPDE6c7	M13zfGN6fG:2b4jpZ{BCe3OjeR?=	M2iwZVUxKM7:TR?=	MVi3NkBp	M2HmcmROW09?	MlrQTWM2OD1zLkOg{txO	NUfaTIJtOTh2OUS0OlM>
Human microvascular epithelial cell	NFPBfldEgXSxdH;4bYMhSXO\|YYm=	MnjBOVAh\|ryP	M{O1OlczKGh?	NXHaTZRPTE2VTx?=	M1\xN2lEPTB;MT6zJO69VQ>?	NGnBT5UyQDR7NES2Ny=>
Hup T3	NXH6fVNYS3m2b4TvfIlkKEG\|c3H5	MkTyOVAh\|ryP	M1jweVczcA>?	Mn3JSG1UVw>?	MXfJR\|UxRTBwODFOwG0>	MXqxPFQ6PDR4Mx?=
Mia Paca2	NEDE[XlEgXSxdH;4bYMhSXO\|YYm=	NEDJN202OCEQvF2=	MXi3Nog>	MXrEUXNQ	NXrHNplUUUN3ME2xMlEh\|ryP	MVuxPFQ6PDR4Mx?=
Panc 04.03	M3;tfGN6fG:2b4jpZ{BCe3OjeR?=	M1zBWFUxKM7:TR?=	MoniO\|Jp	NF7zVolFVVOR	M{PUVmlEPTB;MT6yJO69VQ>?	M4Lk[FE5PDl2NE[z
SU 86.86	MkniR5l1d3SxeHnjJGF{e2G7	M{jUNlUxKM7:TR?=	MlSxO\|Jp	MkjGSG1UVw>?	NVXKU\|VGUUN3ME2xMlMh\|ryP	M3v4UFE5PDl2NE[z
HEK293	MUXLbY5ie2ViQYPzZZk>		Mnv0N{Bp		M{DFTmlvcGmkaYTpc44hd2ZicnXjc41jcW6jboSgTGRCSzZiZYjwdoV{e2mxbjD3bZRpKEmFNUCgc4YhOC5yMUmg{txO	NEeyT2wyQDV3OE[2PS=>
HeLa	NIf6b3ZMcW6jc3WgRZN{[Xl?		NHuy[pgzKGh?		MVPJcohq[mm2aX;uJI9nKG63Y3zlZZIhUESDQzD3bZRpKEmFNUCgc4YhOC5yOEOg{txO	NIKzblQyQDV3OE[2PS=>
RAW264.7	MkTCSpVv[3Srb36gRZN{[Xl?	MYmyJO69VQ>?	Ml;LN{42KGh?	M{fudGROW09?	NVWyWnJlSW62aX3hcIFzcWGuIHHjeIl3cXS7IHHnZYlve3RiUHzhd41w\Gm3bTDmZYxkcXCjcoXtJIlv\mWldHXkJJdqfGhiSVO1NEBw\iByLkGxJO69VQ>?	NVXrbo4zOTh4NES5Olk>
NB4			MnHoOFhp	MkDaSG1UVw>?	M1vN[mlEPTB;MD62JO69VQ>?	NIT6UVEyQDd{M{O0PS=>
HEK293	MoizSpVv[3Srb36gRZN{[Xl?	NWjCfIt4OTBizszN	MmDTNlQhcA>?	NYqzT2FOTE2VTx?=	MYDBZ5RqfmG2aX;uJI9nKG2xdYPlJHdvfDOjIIPp[45idGmwZzDlfJBz\XO\|ZXS=	NXjNU206OTlyMkK2O\|U>
HCT116	NGLheXNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M3PnbVczcA>?	MVnEUXNQ	NVjxO4dDUUN3ME2wMlMyKM7:TR?=	NH[5W5IyQTB6NEK5OC=>
HeLa	M2XVS2tqdmG\|ZTDBd5NigQ>?	Ml7vNkDPxE1?	NUDEV\|d6OzBibXnu	MWXEUXNQ	MX\Jcohq[mm2aX;uJI9nKEiGQVOyJIlvKGi3bXHuJGhmVGFiY3XscJMhf2m2aDDJR\|UxKG:oIECuNUDPxE1?	NVfPe48zOTlyOESyPVQ>
IGROV1	NX[wW4N3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NG\pW2s4OiCq	M3rlb2ROW09?	Ml64TWM2OD1{LkKg{txO	M4DIRVE6ODh2Mkm0
IGROV1	MVrLbY5ie2ViQYPzZZk>	M3vLbFUh\|ryP	MU[yOEBp	NXS2fmlnTE2VTx?=	NVvkcm9vUW6qaXLpeIlwdiCxZjDISGFEKGG\|c3Xzd4VlKGG\|IIC1N{Bi[2W2eXzheIlwdg>?	MYexPVA5PDJ7NB?=
IGROV1	MYTLbY5ie2ViQYPzZZk>	MlrXNVAh\|ryP	NH3ZS481KGh?	MVrEUXNQ	Mn7pTY5pcWKrdHnvckBw\iCKRFHDJIF{e2W\|c3XkJIF{KGirc4TvcoUuUDRiYXPleJlt[XSrb36=	M1:3PVE6ODh2Mkm0
IGROV1	M1nMUWtqdmG\|ZTDBd5NigQ>?	NEHj[pgyOCEQvF2=	NWHBO4JTPCCq	MVzEUXNQ	NHftdYhKdmirYnn0bY9vKG:oIFjERWM3KGG\|c3Xzd4VlKGG\|IHHsdIhiNXS3YoXsbY4h[WOndInsZZRqd25?	MV6xPVA5PDJ7NB?=
T24	MkHRT4lv[XOnIFHzd4F6		MV:zJIg>		MUXJcoR2[3Srb36gc4YhcGm\|dH;u[UBJOyCjY3X0fYxifGmxbjD3bZRpKEWFNUCgc4YhOC5zMjFOwG0>	M2PvVlE6ODh2M{m1
T24	NFLqdHlMcW6jc3WgRZN{[Xl?		MXWzJIg>		NVnpbnZVUW6mdXP0bY9vKG:oIHHsdIhiKHS3YoXsbY4h[WOndInsZZRqd25id3n0bEBGSzVyIH;mJFAvOjVizszN	NG\5S\|YyQTB6NEO5OS=>
HeLa	NV76R213U2mwYYPlJGF{e2G7		MVKxOUBucW5?	M4r0cWROW09?	NULoWY1kUW6qaXLpeIlwdiCxZjDISGFEPiCocn;tJI52[2ynYYKg[Zh1emGldDD3bZRpKEmFNUCgc4YhOC5yOEW1JO69VQ>?	Ml7sNVkxQTN6OES=
HeLa	NWnQeJlwU2mwYYPlJGF{e2G7		NGjGdWkyPSCvaX6=	M1TsXWROW09?	NFrOT2RKdmirYnn0bY9vKG:oIFjERWM5KG[{b32gcpVkdGWjcjDlfJRz[WO2IIfpeIghUUN3MDDv[kAyNjh4IN88US=>	NIfhXmkyQTB7M{i4OC=>
NCI-H69	MUjDfZRwfG:6aXOgRZN{[Xl?		NUnKUYVWPzJiaB?=	NH2zZ3dFVVOR	NUPPXJU1UUN3ME2yMlA3KM7:TR?=	MYKxPVA6Ozh6NB?=
SKMES1	MoOwR5l1d3SxeHnjJGF{e2G7		NYjDUZdSPzJiaB?=	NIfkR4lFVVOR	NFXJXmlKSzVyPUKuOFIh\|ryP	MYKxPVA6Ozh6NB?=
S2	MVTLbY5ie2ViQYPzZZk>	NEj6cGcxNjFvMUCg{txO	NV\xNIdQOSCq		MWjJcohq[mm2aX;uJI9nKFCuYYPtc4RqfW1iZnHsZ4lx[XK3bTDISGFEOSCneIDy[ZN{\WRid3n0bEBKSzVyIH;mJFAvODV7IN88US=>	MkPxNVk{OTd2NUC=
SHSY5Y	NVjJeJlnU2mwYYPlJGF{e2G7	NEXrfIUyOCEQvF2=	Mn35OFghcA>?	MXfEUXNQ	NUDIN3dGUW6qaXLpeIlwdiCxZjDISGFEKHerdHigTWM2OCCxZjCwMlUh\|ryP	NFXJPGgyQTN2NEG3OS=>
SHSY5Y	M4fpOmN6fG:2b4jpZ{BCe3OjeR?=	MnrINVAh\|ryP	NIfvSoo1QCCq	NGLRVItFVVOR	M4O4ZmlEPTB;MjFOwG0>	MlXVNVk{PDRzN{W=
DMS114	NGftXpJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MUS0PEBp		MXvHTVUxRTJwOTFOwG0>	NYjhUohLOTl2MUmyNFU>
HBC5	NXyzXnFMT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NIO1UIo1QCCq		M4ftcGdKPTB;MUeg{txO	MoXZNVk1OTl{MEW=
SNB78	M33zWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MVO0PEBp		MXfHTVUxRTF4IN88US=>	Mnq0NVk1OTl{MEW=
HeLa	NHnaclZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		NGe5T5I4OiCq	Mnz2SG1UVw>?	MlfHTWM2OD1yLkS2JO69VQ>?	MkHSNVk1PDF6NE[=
BHK	Mm\ET4lv[XOnIFHzd4F6	MUm1JO69VQ>?	MlztNlQhcA>?	MmLwSG1UVw>?	MV7Jcohq[mm2aX;uJI9nKEiGQVO3JIV5eHKnc4Pl[EBie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDwcIF{dWFibXXtZpJidmViRnTlcJRiPTB6IFPGWHIheHKxdHXpci=>	M1fMNFE6QTZ4N{i5
CFBE41o-	M3fOZmtqdmG\|ZTDBd5NigQ>?	MXy1JO69VQ>?	NVjKUGRCQCCq	MWnEUXNQ	NXXJcnd7UW6qaXLpeIlwdiCxZjDISGFEKGG\|c3Xzd4VlKGG\|IHj5dIVz[WOndInsZZRqd25ib3[gbIl{fG:wZTDINy=>	NVXZd5BvOTl7Nk[3PFk>
CFBE41o-	NGHxW\|BMcW6jc3WgRZN{[Xl?	MV[1JO69VQ>?	M{LvO\|QhcA>?	MkDGSG1UVw>?	NFPuO4dKdmirYnn0bY9vKG:oIFjERWMh[XO\|ZYPz[YQh[XNiaX7jdoVie2ViaX6gcZV1[W62IF\k[Yx1[TVyODDDSnRTKHC{b4TlbY4hdGW4ZXy=	NECzR5QyQTl4Nke4PS=>
CFBE41o-	MkTpT4lv[XOnIFHzd4F6	M4Lo[VEh\|ryP	MXixJIg>	NUfQSVhbTE2VTx?=	NWC2SVJnUW6qaXLpeIlwdiCxZjDISGFEKGG\|c3Xzd4VlKGG\|IHnuZ5Jm[XOnIHnuJGNHXFJicILveIVqdiCuZY\lcC=>	NVriXXJ3OTl7Nk[3PFk>
Primary bronchial epithelial cell	NV7GZpQxU2mwYYPlJGF{e2G7	MVKxJO69VQ>?	MojjNlQhcA>?	MYDEUXNQ	NUTxc2M2UW6qaXLpeIlwdiCxZjDISGFEPyCjc4Pld5Nm\CCjczDpcoR2[3Srb36gc4YhdXW2YX70JGZl\Wy2YUWwPEBETlSUIIDyc5RmcW5iYYDpZ4FtKHO3cn\hZ4UhdG:lYXzpfoF1cW:w	MlLmNVk6PjZ5OEm=
CFBE41o-	MoS2T4lv[XOnIFHzd4F6	NH3NXI0yKM7:TR?=	M1LMTFUh\GG7cx?=	MUHEUXNQ	M3jKVmlvcGmkaYTpc44hd2ZiSFTBR\|ch[XO\|ZYPz[YQh[XNiaX7jdoVie2ViaX6gd5Ri[mmuaYrheIlwdiCxZjDG[IVtfGF3MEigR2ZVWiCycn;0[Ylv	NV6yXlc1OTl7Nk[3PFk>
CFBE41o-	MYnLbY5ie2ViQYPzZZk>	NIj5UXUyKM7:TR?=	NH[5WFczPCCq	M3rLcGROW09?	NWW3XYc6UW6qaXLpeIlwdiCxZjDISGFEPyCjc4Pld5Nm\CCjczDpcoNz\WG\|ZTDpckBH\GWudHG1NFghS0[WUjDwdo91\WmwIITyZYZncWOtaX7n	M3[1O\|E6QTZ4N{i5
CFBE41o-	NUn5PGFiU2mwYYPlJGF{e2G7	NHvlbm82KM7:TR?=	NV\pcVJUOjRiaB?=	NIXZRZdFVVOR	Ml3aTY5pcWKrdHnvckBw\iCKRFHDO{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDyZZRmKG:oIH3heJVz[XSrb36gc4YhS0[WUjDwdo91\WmwIITvJIl1eyCpbInjc4Zwem1?	MnvuNVk6PjZ5OEm=
CFBE41o-	MmXKT4lv[XOnIFHzd4F6	M3jGXFUh\|ryP	MUCyOEBp	Mk\mSG1UVw>?	NELaflZKdmirYnn0bY9vKG:oIFjERWM4KGG\|c3Xzd4VlKGG\|IHnuZ5Jm[XOnIHnuJJN1[WKrbHn0fUBw\iCIZHXseIE2ODhiQ1\UVkBxem:2ZXnu	MVqxPVk3Pjd6OR?=
CFBE41o-	NV\sRopJU2mwYYPlJGF{e2G7	NEHnT4o2KM7:TR?=	NIH5co0zPCCq	MmTBSG1UVw>?	NHHLVFJKdmirYnn0bY9vKG:oIFjERWM4KGG\|c3Xzd4VlKGG\|IHPvdpJm[3Srb36gc4YhdXW2YX70JGZl\Wy2YUWwPEBETlSUIITyZYZncWOtaX7nJJRwKGOnbHygd5Vz\mGlZTDhd{BodHmlb3\vdo0>	M2HIOFE6QTZ4N{i5
Primary bronchial epithelial cell	M4\aO2tqdmG\|ZTDBd5NigQ>?	MWK1JO69VQ>?	NWfUN2FmOjRiaB?=	NWPkOZd{TE2VTx?=	MXXJcohq[mm2aX;uJI9nKEiGQVOgZZN{\XO\|ZXSgZZMhcW6mdXP0bY9vKG:oIH31eIFvfCCIZHXseIE2ODhiQ1\UVkBxem:2ZXnuJIFxcWOjbDDzeZJn[WOnIHzvZ4FtcXqjdHnvci=>	NF7H[nIyQTl4Nke4PS=>
Primary bronchial epithelial cell	MWTLbY5ie2ViQYPzZZk>	M3y1NlEh\|ryP	NUXocFVoQTZiaB?=	MWrEUXNQ	NEj3dI1KdmirYnn0bY9vKG:oIFjERWM4KGG\|c3Xzd4VlKGG\|IHnuZ5Jm[XOnIHnuJJNpd3K2IHPpdoN2cXRiY4XydoVvfHN?	NIDjO24yQTl4Nke4PS=>
BxPC3	MUXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M3HDVVczKGh?		M3fDRWlEPTB;Mj63JO69VQ>?	Mn\WNlAyPDN5N{i=
CAL27	MoPyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		M4i5Z\|czKGh?		MmWzTWM2OD1\|LkeyJO69VQ>?	Mom1NlAyPDN5N{i=
Capan1	MlrrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NWDNN4l[PzJiaB?=		NF;wbnJKSzVyPUeuN{DPxE1?	MWeyNFE1Ozd5OB?=
HCC827	NVr0W\|V5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NF7D[244OiCq		MXHJR\|UxRTFwODFOwG0>	NEXm[WIzODF2M{e3PC=>
LNCAP	MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MVO3NkBp		NHLMb\|lKSzVyPUCuOVgh\|ryP	MoLvNlAyPDN5N{i=
NCI-H2122	NUfIS3R2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NWjCfZFHPzJiaB?=		MYjJR\|UxRTdwNTFOwG0>	NGGx[mczODF2M{e3PC=>
NCI-H358	NUnKc49DT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MVW3NkBp		M{Sxe2lEPTB;Mj61JO69VQ>?	NWfHOmpFOjBzNEO3O\|g>
SCC15	MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NVTl[IYzPzJiaB?=		NYH5SI5{UUN3ME2yMlQ6KM7:TR?=	NYTsepBMOjBzNEO3O\|g>
SCC25	NHTBcpJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M1Kx[\|czKGh?		NGPvd\|JKSzVyPUGuPVMh\|ryP	NVjNdGkzOjBzNEO3O\|g>
SKHEP1	NYXwNFlyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NVv0bY9QPzJiaB?=		MX\JR\|UxRTNwNE[g{txO	NEPaPYMzODF2M{e3PC=>
BJ	NYrnbId2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NVnMb2VYOTByIN88US=>	NWOxbJk6PDhiaB?=	NX\he5FVTE2VTx?=	MYPHdo94fGhiaX7obYJqfGmxbjDheEAxNjB3IITvJFExOCC3TR?=	NUTG[HQzOjBzNEO4OFA>
MUF	M1;a[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NYXSfGZSOTByIN88US=>	NVvsOIE3PDhiaB?=	M13jdWROW09?	NX3BXmJ1T3Kxd4ToJIlvcGmkaYTpc44h[XRiMD6wOUB1dyBzMECgeW0>	M3rlb\|IxOTR\|OESw
Caco-2	NHfnNY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MkPBNVAxKM7:TR?=	MXq0PIg>	NWDKPIJuTE2VTx?=	NYDafm5OUUN3ME24MlEh\|ryP	M2izbFIxOTR\|OESw
Caco-2	NIPBdINMcW6jc3WgRZN{[Xl?	NV:yUVZuPSEQvF2=	NH;abnY1KGh?	M2PYVWROW09?	MmXhTY5lfWO2aX;uJI9nKEiGQVOtcYVlcWG2ZXSgbIl{fG:wZTDhZ4V1gWyjdHnvckBKSzVyIH;mJFAvODN5IN88US=>	MXuyNFE1Ozh2MB?=
Caco-2	NHHvWY5McW6jc3WgRZN{[Xl?	MWOwMlMyPiCwTTD0c{A{OS54IN88US=>	MWW0JIg>	MVXEUXNQ	MoHPSZghfmm4bzDpcohq[mm2aX;uJI9nKGi3bXHuJGhFSUNzIIfpeIghUUN3MDDv[kAxNjFzOTFOwG0>	NYXn[YpxOjBzNEO4OFA>
Caco-2	MkXqT4lv[XOnIFHzd4F6	M2jHO\|AvOzF4IH7NJJRwKDNzLk[g{txO	MUK0JIg>	MV\EUXNQ	M4S2SmV5KH[rdn:gbY5pcWKrdHnvckBw\iCqdX3hckBJTEGFMzD3bZRpKEmFNUCgc4YhOC5zNEeg{txO	NFjRO4IzODF2M{i0NC=>
Caco-2	M3zNUmtqdmG\|ZTDBd5NigQ>?	NIWzdpk3NjN{IH7NJJRwKDZ\|MjFOwG0>	NY\BdpRkPCCq	NFTQN2FFVVOR	M2\0cmV5KH[rdn:gbY5pcWKrdHnvckBw\iCqdX3hckBJTEGFNTD3bZRpKEmFNUCgc4YhOTJwNjFOwG0>	NHrUWoUzODF2M{i0NC=>
Caco-2	M{e5e2tqdmG\|ZTDBd5NigQ>?	MmHMOk4{OiCwTTD0c{A3OzJizszN	M2O1NFQhcA>?	MmXuSG1UVw>?	M3vFRmV5KH[rdn:gbY5pcWKrdHnvckBw\iCqdX3hckBJTEGFNzD3bZRpKEmFNUCgc4YhPDFizszN	MkfONlAyPDN6NEC=
Caco-2	MmmwT4lv[XOnIFHzd4F6	MlPRNE4{OTZibl2geI8hOzFwNjFOwG0>	NXXX[XAyPCCq	MVXEUXNQ	MWTFfEB3cX[xIHnubIljcXSrb36gc4YhcHWvYX6gTGRCSzZ?	NEDNRZgzODF2M{i0NC=>
HepG2	NH21UnpMcW6jc3WgRZN{[Xl?	MV[1JO69VQ>?	MorNOog>	M2r0e2ROW09?	NGDnb\|ZKdmS3Y4Tpc44hd2ZiSFTBR{1u\WSrYYTl[EBpcXO2b37lJIFk\XS7bHH0bY9v	M{PaNlIxOTR\|OESw
HepG2	M32zU2tqdmG\|ZTDBd5NigQ>?	MYi1JO69VQ>?	M1r2XFZp	NHzxWWVFVVOR	NFH2fXRKdmS3Y4Tpc44hd2ZiSFTBR{1u\WSrYYTl[EBpcXO2b37lJIh6eGW{YXPleJlt[XSrb36=	NGPXSWwzODF2M{i0NC=>
HepG2	NYjNTnlnU2mwYYPlJGF{e2G7	M4O1TFUh\|ryP	NVXFXXZ7Pmh?	NYT2b403TE2VTx?=	NFPPcWtKdmS3Y4Tpc44hd2ZiSFTBR{1u\WSrYYTl[EBidHCqYT30eYJ2dGmwIHHj[ZR6dGG2aX;u	M2\MPVIxOTR\|OESw
HepG2	M1TEb2tqdmG\|ZTDBd5NigQ>?	MoS1OUDPxE1?	MUi2bC=>	MVHEUXNQ	MYjJcoR2[3Srb36gc4YhUESDQz3t[YRq[XSnZDDIN{9JPCCqaYP0c45mKGGlZYT5cIF1cW:w	NHnP[nYzODF2M{i0NC=>
COLO205	M3nXZWtqdmG\|ZTDBd5NigQ>?	MX2xNEDPxE1?	MYKyOEBp	NFv2VVNFVVOR	NUjOZmp[UW6qaXLpeIlwdiCxZjDISGFEOSCjc4Pld5Nm\CCjczDpcoR2[3Srb36gc4YhcGm\|dH;u[UBJOyCjY3X0fYxifGmxbjD3bZRpKEmFNUCgc4YhOi5{IN88US=>	NVKyc4hvOjB2NUGzO\|g>
SCC4	NYjLRXE5U2mwYYPlJGF{e2G7	MXGxJO69VQ>?	NFrYN5QzPGh?		M4jYfGlvcGmkaYTpc44hd2ZiSFTBR{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjD0eYJ2dGmwIHHj[ZR6dGG2aX;u	MV2yNFQ2OjJ{NR?=
SCC4	M3HYR2tqdmG\|ZTDBd5NigQ>?	MWexJO69VQ>?	Mnq2NlRp		NX\n[W0xUW6qaXLpeIlwdiCxZjDISGFEKGG\|c3Xzd4VlKGG\|IHnuZ5Jm[XOnIHnuJIhqe3SxbnWgZYNmfHmuYYTpc44>	NUS2dJRYOjB2NUKyNlU>
SCC4	MYjGeY5kfGmxbjDBd5NigQ>?	NXjkRXZQOSEQvF2=	NGLtRYQ2KG2rbh?=		M1jlSmFod26rc4SgZYN1cX[rdImgZZQhXkSUIHHzd4V{e2WmIHHzJIlv\HWldHnvckBw\iCFWWCyOEBo\W6nIHX4dJJme3Orb36=	MU[yNFQ2OjJ{NR?=
NB4	NXXJdXpYTnWwY4Tpc44hSXO\|YYm=	MWK1JO69VQ>?	MYSyOEBp	NYHtNll3TE2VTx?=	MnXBR4VtdCCleXPs[UBienKnc4SgZZN{\XO\|ZXSgZZMhcW6lcnXhd4UhcW5iYXPjeY12dGG2aX;uJIF1KHC{ZT3HNUBxcGG\|ZR?=	MoLvNlA1QTF2NEC=
NB4	M3v5TmtqdmG\|ZTDBd5NigQ>?	NYn3WINVPSEQvF2=	NHjXS4gzPCCq	NXrHSmxoTE2VTx?=	Mne5TY5pcWKrdHnvckBw\iCKRFHDJIF{e2W\|c3XkJIF{KGmwY4LlZZNmKGmwIHHj[ZR6dGG2ZTD0eYJ2dGmwIHzleoVt	MlrxNlA1QTF2NEC=
NB4	MX\GeY5kfGmxbjDBd5NigQ>?	NXO4RWp6PSEQvF2=	M13DbFI1KGh?	MlXrSG1UVw>?	M3fiTmlv\HWldHnvckBw\iCyMkHXRWYyN0OLUEGg[ZhxemW\|c3nvci=>	NIPVRZYzODR7MUS0NC=>
NB4	NVeyPJhKU2mwYYPlJGF{e2G7	MXG1JO69VQ>?	NVvkZ3pMOjRiaB?=	NGLNdnVFVVOR	M2XXR2lvcGmkaYTpc44hd2ZiSFTBR{Bie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDobZN1d26nIFizJIFk\XS7bHH0bY9v	MlTZNlA1QTF2NEC=
NUGC3	NIrNdY5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MWrHTVUxRTJwOUSg{txO	NUO2SmtGOjB6NUC5O\|E>
A549	MYDGeY5kfGmxbjDBd5NigQ>?	MWW1JO69VQ>?	M4fT[FMhcA>?	NVz4TWN2TE2VTx?=	MnTPTY5lfWO2aX;uJI9nKGG3dH;wbIFogSCrbjDoeY1idiCDNUS5JINmdGy\|IHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKEyFM1nJ	MnzMNlA5PTV{MEi=
HUT78	NVXHO\|ZIT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NFKxXJY4OiCq	MX7EUXNQ	MYjHTVUxRTBwMzFOwG0>	NGPJUYgzODh6NEKwPC=>
U937	NWjCbpc3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		M{fWT\|czKGh?	MoLnSG1UVw>?	MmTRS2k2OD1yLkO5JO69VQ>?	NIG2OHozODh6NEKwPC=>
A431	MWnDfZRwfG:6aXOgRZN{[Xl?		NXm2XXZ[PzJiaB?=		MnH2R5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gRVQ{OSClZXzsd{BwfmW{ZYjwdoV{e2mwZzDFS2ZTKHerdHigTWM2OCCxZjC0MlIh\|ryP	NFPkXVAzOTB6ME[yPS=>
A549	NGj5TpdEgXSxdH;4bYMhSXO\|YYm=		MX[3NkBp		NGfSTI5EgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBCPTR7IHPlcIx{KG:4ZYLlfJBz\XO\|aX7nJGhFSUNid3n0bEBKSzVyIH;mJFEvQCEQvF2=	MlXENlExQDB4Mkm=
CAL27	MkTzR5l1d3SxeHnjJGF{e2G7		MX[3NkBp		MknPR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gR2FNOjdiY3XscJMhd3[ncnX4dJJme3OrbnegSWdHWiC5aYToJGlEPTBib3[gN{4zKM7:TR?=	MnvwNlExQDB4Mkm=
HeLa	Ml3OR5l1d3SxeHnjJGF{e2G7		MlrpO\|IhcA>?		NYfQZlVQS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUGWOYTDj[YxteyCxdnXy[ZhxemW\|c3nu[{BJTEGFIIfpeIghUUN3MDDv[kAyNjVizszN	MmC4NlExQDB4Mkm=
Sf21	NWC4dY9MU2mwYYPlJGF{e2G7		MU[zJIg>		MmHOTY5pcWKrdHnvckBw\iCIbHHnJJRi\2enZDDoeY1idiC{ZXPvcYJqdmGwdDDISGFEQCCneIDy[ZN{\WRid3n0bEBKSzVyIH;mJFEvOiEQvF2=	NGLGXYMzOTB6ME[yPS=>
SKBR3	M1XRbmN6fG:2b4jpZ{BCe3OjeR?=		MU[3NkBp		MVLDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDTT2JTOyClZXzsd{BwfmW{ZYjwdoV{e2mwZzDISXIzKHerdHigTWM2OCCxZjCyMlYh\|ryP	NVfGOYlIOjFyOEC2Nlk>
SKOV3	MUnDfZRwfG:6aXOgRZN{[Xl?		MnrKO\|IhcA>?		MkPGR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gV2tQXjNiY3XscJMhd3[ncnX4dJJme3OrbnegTGVTOiC5aYToJGlEPTBib3[gNk4zKM7:TR?=	NXq1fmlYOjFyOEC2Nlk>
COR-L23	NGi2Z2xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NHS3PXYyOCEQvF2=	NYjMRlJCPzJiaB?=	NFX3fZpFVVOR	Mm\4S2k2OD1zLkGg{txO	NFf1PGEzOTB6ME[0Oy=>
DU145	MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MYqxNEDPxE1?	NX\WZZd4PzJiaB?=	MYDEUXNQ	NHrPXopIUTVyPUGuNFUh\|ryP	MlixNlExQDB4NEe=
LoVo	MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NXnXTHdxOTBizszN	M2XDN\|czKGh?	NFzTZYlFVVOR	M1;mfmdKPTB;MT63JO69VQ>?	M1vydVIyODhyNkS3
MCR5-SV2	MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M2\DWVExKM7:TR?=	M3\BflczKGh?	NEfR[HVFVVOR	MUfHTVUxRTJwMTFOwG0>	MWeyNVA5ODZ2Nx?=
HCT116	NH7RdY5McW6jc3WgRZN{[Xl?	MoXxN\|Ah\|ryP	NV3lVpBOOzBiaB?=	MkHDSG1UVw>?	MlryTY5pcWKrdHnvckBw\iCKRFHDOkBie3Onc4Pl[EBieyCrbnT1Z5Rqd25ib3[gZYxxcGFvdIXieYxqdiCjY3X0fYxifGmxbh?=	NH7tOYEzOTB6ME[0Oy=>
HCT116	MoftT4lv[XOnIFHzd4F6	NX71TpA2OzBizszN	NVrkWZBNOzBiaB?=	M2e0VWROW09?	M4T2VGlvcGmkaYTpc44hd2ZiSFTBR\|Eh[XO\|ZYPz[YQh[XNiaX7keYN1cW:wIH;mJIhqe3SxbnWgTFNMQSCjY3X0fYxifGmxbh?=	M3ryWlIyODhyNkS3
U937	M{jpbmtqdmG\|ZTDBd5NigQ>?	NUmydFRUPSEQvF2=	NEjpU3MzPCCq	NWLTTZltTE2VTx?=	M4\oeWlvcGmkaYTpc44hd2ZiaHnzeI9v\SCjY3X0fYx1emGwc3\ldoF{\SCjc4Pld5Nm\CCjczDpcoNz\WG\|ZTDv[kBi[2W2eXzheIlwdiCxZjDobZN1d26nIFizJIF1KEt7	NUXZVWtROjF{OUK0PVI>
U937	NIjtW4dMcW6jc3WgRZN{[Xl?	NYPYTG45PSEQvF2=	NVfNbo9GOjRiaB?=	M1vn[mROW09?	NYL1TYsyUW6qaXLpeIlwdiCxZjDobZN1d26nIHHj[ZR6dHS{YX7z[oVz[XOnIHHzd4V{e2WmIHHzJIlv[3KnYYPlJI9nKGGlZYT5cIF1cW:wIH;mJIhqe3SxbnWgTFMh[XRiS{G4	NEDUT4MzOTJ7MkS5Ni=>
U937	M1vNXmtqdmG\|ZTDBd5NigQ>?	NVjYXmFkPSEQvF2=	NXy2RmQyOjRiaB?=	NITNenZFVVOR	NVPZTlJTUW6qaXLpeIlwdiCxZjDobZN1d26nIHHj[ZR6dHS{YX7z[oVz[XOnIHHzd4V{e2WmIHHzJIlv[3KnYYPlJI9nKHCjbj3hZ4V1gWyjdHXkJIhqe3SxbnWgTFQhdGW4ZXy=	NELEWW4zOTJ7MkS5Ni=>
U937	NEnqNZVMcW6jc3WgRZN{[Xl?	M4izfFUh\|ryP	NH:yWJgyPSCvaX6=	MlzXSG1UVw>?	M4L1eGlvcGmkaYTpc44hd2ZiaHnzeI9v\SCjY3X0fYx1emGwc3\ldoF{\SCjc4Pld5Nm\CCjczDpcoNz\WG\|ZTDv[kBpcXO2b37lJGg{KGGlZYT5cIF1cW:wIHzleoVt	MmDWNlEzQTJ2OUK=
A2780	NV\6S\|Z1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		MX:5OkBp	M4qySmROW09?	NFfoVXdKSzVyPUGuOlIh\|ryP	MoPMNlE3OzR2M{C=
COLO205	NIXXdpZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MlnZPVYhcA>?	M3ezVGROW09?	Moi3TWM2OD1{LkGyJO69VQ>?	MV2yNVY{PDR\|MB?=
Hep3B	NVrON2QzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NWX6c2J2PDhiaB?=	NX\COGdkTE2VTx?=	NI[4eWlIUTVyPUGuNlEh\|ryP	NX;wPJZGOjF5MUKxOFY>
GM11272	M2jBdWZ2dmO2aX;uJGF{e2G7	NEP0VmwyODBibl2=	M1zyblczKGh?	NFq2doRFVVOR	NEHObpBT\WGldHn2ZZRqd25ib3[gUYVEeDJibYX0ZY51KGW6cILld5Nqd25iYYSgNVAhfG9iMUCwJI5O	MUGyNVg1ODdzNh?=
CFBE41o	NH;qZoZMcW6jc3WgRZN{[Xl?	NGfkSXo2KM7:TR?=		MoD2SG1UVw>?	M{i2cWRwf25icnXneYxifGmxbjDv[kBJTEGFNzDheEAxNjJidH:gOUB2VQ>?	M13MflIyQTh2OUW4
CFBE41o	NUDIOmRbTnWwY4Tpc44hSXO\|YYm=	NXH3[4pQOSEQvF2=	NUjWe4ZTOjRiaB?=	NWPEflF5TE2VTx?=	MkXCVoV{fG:{YYTpc44hd2ZiQ1\UVkBl\Wy2YV[1NFghdXW2YX70JJRz[W[oaXPrbY5oKHSxIHPlcIwhe3W{ZnHj[UBieyCpbInjc4Zwem2\|	M3\yRVIyQTh2OUW4
DU145	NUH0[mkxU2mwYYPlJGF{e2G7	MViyMlUh\|ryP	MVOyOEBp	MVnEUXNQ	M3n6TGlvcGmkaYTpc44hd2ZiSFTBR{Bie3Onc4Pl[EBieyC3cILl[5Vt[XSrb36gc4YheDJzd3HmNUBxem:2ZXnuJIV5eHKnc4Ppc44>	MnOwNlIzPjBzNk[=
DU145	MmPBT4lv[XOnIFHzd4F6	M13JNlUh\|ryP	NHvaclAzPCCq	NFjZ[nRFVVOR	NHHINYRKdmirYnn0bY9vKG:oIFjERWMh[XO\|ZYPz[YQh[XNiaHnzeI9v\SCKNDDhZ4V1gWyjdHnvci=>	MlrRNlIzPjBzNk[=
DU145	NInh[W9McW6jc3WgRZN{[Xl?	Mor6OUDPxE1?	MYCyOEBp	M1PvXmROW09?	MV3Jcohq[mm2aX;uJI9nKEiGQVOgZZN{\XO\|ZXSgZZMhcGm\|dH;u[UBJOyCqeYDldoFk\XS7bHH0bY9v	MUSyNlI3ODF4Nh?=
786-0	M4\uemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NITCd\|g3NjJizszN	NXjUe21zPzJiaB?=	NELEO\|hFVVOR	Mn3YS2k2OD1\|LkKg{txO	NIXjRZczOjR\|NU[2PS=>
A498	M2HmbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NXfp[FlvPi5{IN88US=>	MYq3NkBp	MkHNSG1UVw>?	Mn7YS2k2OD1zLk[g{txO	M4PzdVIzPDN3Nk[5
A549/ATCC	MlXiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NUXJRmFLPi5{IN88US=>	NGOyfJQ4OiCq	NUKzcHpxTE2VTx?=	NWfaN\|cyT0l3ME2xMlYh\|ryP	MoHPNlI1OzV4Nkm=
ACHN	MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NHjTXoc3NjJizszN	MoCzO\|IhcA>?	NV76SVVkTE2VTx?=	MljIS2k2OD1zLkOg{txO	NF7rdngzOjR\|NU[2PS=>
BT549	NVLYfZdDT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NG\0cZg3NjJizszN	NHG1dWM4OiCq	M1vJVGROW09?	M3vZUGdKPTB;MT6zJO69VQ>?	MVmyNlQ{PTZ4OR?=
EKVX	MmKxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MXy2MlIh\|ryP	M4T4O\|czKGh?	NWrTOYNRTE2VTx?=	M4rZcmdKPTB;MT6zJO69VQ>?	NIHLVoUzOjR\|NU[2PS=>
HCT15	MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MnK2Ok4zKM7:TR?=	MnHtO\|IhcA>?	MnL4SG1UVw>?	Mk\GS2k2OD1{LkWg{txO	M1SyPFIzPDN3Nk[5
HOP92	NUHTVoh6T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NGPubVc3NjJizszN	MlvIO\|IhcA>?	MVXEUXNQ	NYT5UGQ1T0l3ME20JO69VQ>?	MoLLNlI1OzV4Nkm=
IGROV1	MnPKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M3La[\|YvOiEQvF2=	MXS3NkBp	M1\pXGROW09?	MXvHTVUxRTFwMzFOwG0>	NXXmSGNKOjJ2M{W2Olk>
LOXIMVI	M3jnUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MlzXOk4zKM7:TR?=	MoHkO\|IhcA>?	MVPEUXNQ	NY\yW4E2T0l3ME2xJO69VQ>?	MXOyNlQ{PTZ4OR?=
M14	Ml;CS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	MkntOk4zKM7:TR?=	NVuwb2xXPzJiaB?=	M3nxO2ROW09?	NVnJWmZOT0l3ME2xMlMh\|ryP	NE\5[mQzOjR\|NU[2PS=>
MALME-3M	NHrxR5lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	Mof5Ok4zKM7:TR?=	M3\Y[lczKGh?	MoHDSG1UVw>?	MYTHTVUxRTBwM{Kg{txO	MUSyNlQ{PTZ4OR?=
MCF10A	M13Oc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MUC2MlIh\|ryP	NYWyd5BnPDhiaB?=	MU\EUXNQ	MXzHTVUxRTlwNjFOwG0>	MUeyNlQ{PTZ4OR?=
MDA-MB-435	MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MVK2MlIh\|ryP	NYXHb3A4PzJiaB?=	NHnPSY9FVVOR	M2Dx[mdKPTB;MD61JO69VQ>?	NFXmcnYzOjR\|NU[2PS=>
MDA-MB-468	M4L2fGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M1zSZlYvOiEQvF2=	MYq3NkBp	MUXEUXNQ	NEO3bZBIUTVyPUCuOlMh\|ryP	NH;QTlAzOjR\|NU[2PS=>
MOLT4	NITh[mhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	M3\KSFYvOiEQvF2=	MUO3NkBp	Mor5SG1UVw>?	NGDiWGZIUTVyPUCuOEDPxE1?	MWWyNlQ{PTZ4OR?=
NCI-ADR-RES	NUWycIVrT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NGHt[W83NjJizszN	M2rLVFczKGh?	NVPUTHloTE2VTx?=	NFr2WYRIUTVyPUCuNVYh\|ryP	MXuyNlQ{PTZ4OR?=
NCI-H23	MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M2LSWlYvOiEQvF2=	MkPsO\|IhcA>?	MWLEUXNQ	MYHHTVUxRTFizszN	Mn7DNlI1OzV4Nkm=
NCI-H322M	NV;vbmgzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M2PCUFYvOiEQvF2=	NILRPII4OiCq	MkG4SG1UVw>?	NV;1PG5ET0l3ME2wMlc6KM7:TR?=	MkD0NlI1OzV4Nkm=
NCI-H460	M3XB[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NE\se2g3NjJizszN	MUS3NkBp	MmK2SG1UVw>?	MUfHTVUxRTBwN{mg{txO	NWPhcXVoOjJ2M{W2Olk>
NCI-H522	MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	Ml;4Ok4zKM7:TR?=	NGXDSI04OiCq	NIr4NG1FVVOR	M4Pib2dKPTB;MD61JO69VQ>?	MXiyNlQ{PTZ4OR?=
OVCAR3	MnHxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M4\S[lYvOiEQvF2=	NWLoV21uPzJiaB?=	M1HrdGROW09?	NYjuTlFxT0l3ME2xMlMh\|ryP	MVKyNlQ{PTZ4OR?=
OVCAR4	MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MUO2MlIh\|ryP	MYq3NkBp	MmjHSG1UVw>?	MoHiS2k2OD12IN88US=>	NF[xNJgzOjR\|NU[2PS=>
OVCAR5	NWnQcZdPT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MYS2MlIh\|ryP	NYPB[Xk5PzJiaB?=	MUXEUXNQ	MUfHTVUxRTBwN{mg{txO	M3XuZVIzPDN3Nk[5
OVCAR8	NYHadGk3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M4nGTVYvOiEQvF2=	M1P5elczKGh?	NIXHOm9FVVOR	M1rWeWdKPTB;MD61JO69VQ>?	MYiyNlQ{PTZ4OR?=
RXF393	NXXLbmljT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	MojrOk4zKM7:TR?=	MX63NkBp	M3LteWROW09?	M1nHWmdKPTB;MT6zJO69VQ>?	MmDyNlI1OzV4Nkm=
SF268	NY\5e4VmT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NIOzdYY3NjJizszN	NX:5SZIyPzJiaB?=	Ml\ISG1UVw>?	MXrHTVUxRTFwNjFOwG0>	NGXwVlkzOjR\|NU[2PS=>
SF295	M3XWemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	M163dlYvOiEQvF2=	MUW3NkBp	M1mx[mROW09?	MoXDS2k2OD1zLk[g{txO	MYGyNlQ{PTZ4OR?=
SF539	MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	Ml\2Ok4zKM7:TR?=	M2mwelczKGh?	NY\hPYh1TE2VTx?=	MXXHTVUxRTJizszN	MnPSNlI1OzV4Nkm=
SK-MEL-2	MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	M3;TN\|YvOiEQvF2=	MWW3NkBp	MkX0SG1UVw>?	Mly4S2k2OD1zLkOg{txO	NEXQW4wzOjR\|NU[2PS=>
SK-MEL-28	M{D3SWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MoWzOk4zKM7:TR?=	M{O0UlczKGh?	M{\pTWROW09?	M3XWS2dKPTB;MTFOwG0>	MUGyNlQ{PTZ4OR?=
SK-MEL-5	NWDlXGdvT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	NGewT3A3NjJizszN	NFXkSJg4OiCq	M3TUO2ROW09?	NHP2WoZIUTVyPUCuOlMh\|ryP	NH60R44zOjR\|NU[2PS=>
SKOV3	M3PPdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MW[2MlIh\|ryP	M2rkc\|czKGh?	MXfEUXNQ	NHLvN2NIUTVyPUGg{txO	NXLyVIJTOjJ2M{W2Olk>
SN12C	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	NHj5[JA3NjJizszN	MVi3NkBp	NHLOcIZFVVOR	NV7uU5lYT0l3ME2yJO69VQ>?	MX6yNlQ{PTZ4OR?=
SNB19	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MXy2MlIh\|ryP	NEnnNos4OiCq	NFrp[FVFVVOR	NGHuc2ZIUTVyPUCuOlMh\|ryP	MWqyNlQ{PTZ4OR?=
SNB75	MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?	MmPWOk4zKM7:TR?=	M{O0SlczKGh?	MXLEUXNQ	MoWwS2k2OD1yLke5JO69VQ>?	NGiyc3QzOjR\|NU[2PS=>
SR	MlL2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	Mlm2Ok4zKM7:TR?=	NFnubGU4OiCq	M4r5RWROW09?	M3[5V2dKPTB;MD60JO69VQ>?	M4\ZWVIzPDN3Nk[5
T47D	NFHYZVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NEX3Z3Q3NjJizszN	MWq3NkBp	NYjidFNKTE2VTx?=	MWTHTVUxRTBwNTFOwG0>	MoXrNlI1OzV4Nkm=
TK10	Ml33S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NYXBNoxCPi5{IN88US=>	MnW5O\|IhcA>?	MlPmSG1UVw>?	NEnvRmdIUTVyPUCuOlMh\|ryP	NWq3dGx7OjJ2M{W2Olk>
UACC257	NGXvTJRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NUCxelI5Pi5{IN88US=>	M{L0UFczKGh?	MUPEUXNQ	NXHydIxET0l3ME2wMlUh\|ryP	Mlj1NlI1OzV4Nkm=
UACC62	NUizdWdET3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=	M3ru[VYvOiEQvF2=	MUC3NkBp	M1q5RmROW09?	NHnleYFIUTVyPUCuOEDPxE1?	NITie5gzOjR\|NU[2PS=>
UO31	NHv1S2NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	NHjKVpY3NjJizszN	MYi3NkBp	NFK5T5pFVVOR	MW\HTVUxRTBwNTFOwG0>	NIH5OnAzOjR\|NU[2PS=>
Hep3B	MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		MYW0PEBp	MlLWSG1UVw>?	NIHTPVVIUTVyPUCuOlkh\|ryP	NXSz[pA4OjJ2M{m4OlM>
BE(2)-C	MnPWS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NXi0SmRHPzJiaB?=	NXS0elNxTE2VTx?=	M3LtcWlEPzB;MjFOwG0>	NWH0Vnp7OjJ7M{KzNVY>
Bel7402	MmnZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NGjybo44OiCq	MYfEUXNQ	MYLHTVkxRTF5IN88US=>	NFewW44zOzB4MUO3Oi=>
Bel7404	M3PtPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MU[3NkBp	MmS4SG1UVw>?	MlLSS2k6OD1zODFOwG0>	NH3CVoozOzB4MUO3Oi=>
BGC823	MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		Ml;TO\|IhcA>?	NFfhRpJFVVOR	MnLHS2k6OD15LkWg{txO	NIfnUHAzOzB4MUO3Oi=>
MGC803	M2\ld2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MU[3NkBp	Mo[xSG1UVw>?	M1PxRWdKQTB;MUCuPEDPxE1?	M1PleVI{ODZzM{e2
SGC7901	MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		Mnr0O\|IhcA>?	NFTOSWNFVVOR	NYXrfG9LT0l7ME25MlQh\|ryP	MVWyN\|A3OTN5Nh?=
SKHEP1	NVjIUm1VT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=		NWK1Vow6PzJiaB?=	NVfwSWlRTE2VTx?=	MUXHTVkxRTF5IN88US=>	MXeyN\|A3OTN5Nh?=
SMMC7721	M2D0TWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		M1\LcVczKGh?	M1TFOWROW09?	M3LqSGdKQTB;MkCg{txO	NV7tSmlEOjNyNkGzO\|Y>
NUGC3	M{HOTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MVuxNEDPxE1?			MVzHTV0zNjl2IN88US=>	MYWyN\|E3OzN\|Mh?=
A2780 CisR	MnzZT4lv[XOnIFHzd4F6		M{XvXlE5KGh?		MWXJcohq[mm2aX;uJI9nKEiGQVOge4l1cCCLQ{WwJI9nKDBwNESg{txO	M2fK[VI{OjV{NkCz
CAL27 sens	M1HDc2tqdmG\|ZTDBd5NigQ>?		Mn76NVghcA>?		M2rLfmlvcGmkaYTpc44hd2ZiSFTBR{B4cXSqIFnDOVAhd2ZiMD6zOkDPxE1?	M2P2[VI{OjV{NkCz
CAL27 CisR	NX;sVGZ2U2mwYYPlJGF{e2G7		NIPRZ3kyQCCq		NFmyTpJKdmirYnn0bY9vKG:oIFjERWMhf2m2aDDJR\|UxKG:oIECuOlEh\|ryP	NHTVOmwzOzJ3Mk[wNy=>
KYSE-510 CisR	NUPkVZZyU2mwYYPlJGF{e2G7		NHXmWI8yQCCq		NY\D[2U1UW6qaXLpeIlwdiCxZjDISGFEKHerdHigTWM2OCCxZjCwMlU6KM7:TR?=	NXnmV2t3OjN{NUK2NFM>
KYSE-510 sens	MXfLbY5ie2ViQYPzZZk>		M{HDTVE5KGh?		NHWxO2pKdmirYnn0bY9vKG:oIFjERWMhf2m2aDDJR\|UxKG:oIECuO{DPxE1?	NYnTZo9IOjN{NUK2NFM>
MDA-MB-231 sens	MULLbY5ie2ViQYPzZZk>		M{njbFE5KGh?		NUjldGhxUW6qaXLpeIlwdiCxZjDISGFEKHerdHigTWM2OCCxZjCwMlYyKM7:TR?=	Mn;6NlMzPTJ4MEO=
MDA-MB-231 CisR	MmDaT4lv[XOnIFHzd4F6		NFjuUpAyQCCq		MWfJcohq[mm2aX;uJI9nKEiGQVOge4l1cCCLQ{WwJI9nKDBwNkGg{txO	MmLVNlMzPTJ4MEO=
ES2	MkXGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?		NEfLXoo1QCCq	M3TSRWROW09?	NYDQR4NyUUN3ME2xNk44KM7:TR?=	M2POclI{PDl\|NES5
MDA-MB-231	MVvLbY5ie2ViQYPzZZk>	M3TwcVExKM7:TR?=	NEXkNYs{OCCvaX6=	MmnySG1UVw>?	Mo\KTY5pcWKrdHnvckBw\iCKRFHDNoE>	MXuyN\|Q6OzR2OR?=
MDA-MB-231	MWHLbY5ie2ViQYPzZZk>	M2PQelEh\|ryP	NFK1ZnMzPCCq	M1\JN2ROW09?	M1z4TmlvcGmkaYTpc44hd2ZiSFTBR\|Yh[XO\|ZYPz[YQh[XNiYXPleJlt[XSrb36gcIV3\Wy\|IH;mJJR2[nWuaX6=	Mo\WNlM1QTN2NEm=
HS68	NF3ZVGNEgXSxdH;4bYMhSXO\|YYm=	MVmxNEDPxE1?	M4G3TFczKGh?	M2nOR2ROW09?	NYHHR\|FnUUN3ME20MlYh\|ryP	MVuyN\|U4ODV2Mh?=
MEF	NX3DNIo5S3m2b4TvfIlkKEG\|c3H5	NFzRU5gyOCEQvF2=	M1HD[lczKGh?	MWjEUXNQ	NFLqdpdKSzVyPUSuOEDPxE1?	MkXWNlM2PzB3NEK=
BGC823	MljpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?			NUPF[2FFTE2VTx?=	MmnJS2k2OD1\|LkC5JO69VQ>?	M4fyeVI{PjBzN{C2
High5	NV[2eXFCU2mwYYPlJGF{e2G7		NV:y[nRrOjRiaB?=		NIfiXpJKdmirYnn0bY9vKG:oIHj1cYFvKHKnY3;tZolv[W62IFjERWM3KHerdHigTWM2OCCxZjCwMlA6KM7:TR?=	M{CxUFI{PjB{NUKz
High5	NImxN2ZMcW6jc3WgRZN{[Xl?		Mo\5NlQhcA>?		M{nhbGlvcGmkaYTpc44hd2ZiaIXtZY4hemWlb33ibY5idnRiSFTBR\|Ehf2m2aDDJR\|UxKG:oIECuNVIh\|ryP	M{TuVFI{PjB{NUKz
High5	NHXsdHFMcW6jc3WgRZN{[Xl?		NHPjT3UzPCCq		NWmwV3RtUW6qaXLpeIlwdiCxZjDoeY1idiC{ZXPvcYJqdmGwdDDISGFEOyC5aYToJGlEPTBib3[gNE4yPyEQvF2=	Mn\ONlM3ODJ3MkO=
A549	NGOzNGpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			Mmm4SG1UVw>?	M3XpXmlEPTB;MT6wO\|kh\|ryP	MVeyN\|Y1PDJzMB?=
HCT116	M37VOmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7			NW\YS3lITE2VTx?=	MkjjTWM2OD1yLke1O{DPxE1?	NIrOXVAzOzZ2NEKxNC=>
K562	NF\kfnpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=			M2DmVWROW09?	M1myV2lEPTB;MD62OFUh\|ryP	NH7n[mozOzZ2NEKxNC=>
GBC-SD	M2DN[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	Mmr4OUDPxE1?	NYjvOHZ[PzJiaB?=	M1vP[mROW09?	M1TjcmlEPTB;MUSuPEDPxE1?	Mne5NlM4ODd{NkC=
HGC27	M{jEdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	MnfIOUDPxE1?	M1[5NFczKGh?	NEDJ[HJFVVOR	NUPPbGNFUUN3ME21MlQh\|ryP	MViyN\|cxPzJ4MB?=
HL60	MVrLbY5ie2ViQYPzZZk>	NYjkWWo3PSEQvF2=	NHq4XoEzPCCq	NYrkWYJsTE2VTx?=	NH\afJpKdmirYnn0bY9vKG:oIFjERWM>	NFq2cm8zOzdyN{K2NC=>
Vero	NIOwR5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MnnHO\|IhcA>?	NXTjToZRTE2VTx?=	M1TPZWlEPTB;MD65JO69VQ>?	NEHteZgzOzd6NkS1Ni=>
NCI60	NVLYZoE3S3m2b4TvfIlkKEG\|c3H5		MX[0PEBp	MVrEUXNQ	NInxV5lIUT1yLkWzJO69VQ>?	Ml:5NlQxOTV\|Mke=
SW620	NFXWUplEgXSxdH;4bYMhSXO\|YYm=		MYe0PEBp	M3\NOGROW09?	M3TjdmdKRTBwNUSg{txO	NFrLfoUzPDBzNUOyOy=>
U251	Ml\mR5l1d3SxeHnjJGF{e2G7		M13qflQ5KGh?	MnPYSG1UVw>?	M1\OR2dKRTFwNUOg{txO	M1;qOlI1ODF3M{K3
KM12	MnTQR5l1d3SxeHnjJGF{e2G7		M3e3eFQ5KGh?	M2jDW2ROW09?	MnHFS2k:OS56ODFOwG0>	M4nrWFI1ODF3M{K3
Hs578T	M33OSGN6fG:2b4jpZ{BCe3OjeR?=		MV60PEBp	MlHSSG1UVw>?	MV7HTV01Njh\|IN88US=>	NFLhNFgzPDBzNUOyOy=>
MDA-MB-231	NFXxVpRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		MXG0PEBp		MkPrTWM2OD1yLkG2JO69VQ>?	MliyNlQxQTVyMU[=
MCF7	M4O0bWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MXe0PEBp		M3TGcWdKRTBwNEWg{txO	MUOyOFEyQTV3NR?=
MDA-MB-435	MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		M4nNSFQ5KGh?		M13wU2dKRTBwOEig{txO	M{TBc\|I1OTF7NUW1
AsPC1	NHzNN5BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=	MUezNEDPxE1?	MWe0PEBp	NF3D[3pFVVOR	M2XqR2lEPTB;Mz62OkDPxE1?	M17y[\|I1OTh3M{e4
Jurkat E6.1	Mln0T4lv[XOnIFHzd4F6		MnjsNkBp	M2nLXGROW09?	NIPuPVFKdmirYnn0bY9vKG:oIFjERWM1KHerdHigTWM2OCCxZjCwMlA1KM7:TR?=	M{TsdVI1OjZzOE[y
KG1	MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NW\VOHhSPDhiaB?=		NUTyfnI1UUN3ME2xMlE2KM7:TR?=	M1yxcVI1PTJ3MECz
HEL	NIThWFJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=		M{LlT\|Q5KGh?	NXjMWnZKTE2VTx?=	NWr0V3Q{UUN3ME2wMlQ6KM7:TR?=	NHXOco0zPDZ7NEC1OS=>
HSC3	MlnQR5l1d3SxeHnjJGF{e2G7		NF3rTIMyOiCq	MoraSG1UVw>?	MkHDTWM2OD1yLkexJO69VQ>?	NHvOPVIzPDd4NkW2NC=>
HT-29	M4T5RmN6fG:2b4jpZ{BCe3OjeR?=		M1XYZVEzKGh?	MV;EUXNQ	NUnQPJp{UUN3ME2wMlczKM7:TR?=	MXOyOFc3PjV4MB?=
KB	MoHOR5l1d3SxeHnjJGF{e2G7		M3rQZ\|EzKGh?	M3;3Z2ROW09?	MWLJR\|UxRTBwN{Wg{txO	MVSyOFc3PjV4MB?=
H460	NW\PdXRFS3m2b4TvfIlkKEG\|c3H5		MV[xNkBp	MY\EUXNQ	MX3JR\|UxRTBwOEKg{txO	MUKyOFc3PjV4MB?=
MONE1	NF3PSlVEgXSxdH;4bYMhSXO\|YYm=		NIW2fIoyOiCq	NH3yd2ZFVVOR	MmfaTWM2OD1zLkG4JO69VQ>?	NHXydngzPDd4NkW2NC=>
MKN45	NEfI[W9EgXSxdH;4bYMhSXO\|YYm=		NHHUfowyOiCq	MlnaSG1UVw>?	MojvTWM2OD1zLkK1JO69VQ>?	MkX6NlQ4PjZ3NkC=
TSGH	M{n4WWN6fG:2b4jpZ{BCe3OjeR?=		MlXDNVIhcA>?	NEPrcXhFVVOR	MoLDTWM2OD1{LkC5JO69VQ>?	NUnKRpByOjR5Nk[1OlA>
HL60	M3q5dmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7		MWG3NkBp	MYfEUXNQ	MVnHTVUxRTBwOUOg{txO	NGi4NmUzPDlyMEWwNC=>
HEK293	MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?		NU\BPVFbPzJiaB?=	NWK1b5R3TE2VTx?=	MmjUS2k2OD1zMzFOwG0>	M174PFI1QTByNUCw
Jurkat	MUDDfZRwfG:6aXOgRZN{[Xl?	MWixNFAh\|ryP	M{nOVFczKGh?		M17yeGdKPTB;MD65JO69VQ>?	NWK5VZYzOjR7MEC3OFM>
GM15850	NV:zW5duU2mwYYPlJGF{e2G7	MXiyMlUh\|ryP	NGnveWo6PiCq	NVnKWnpVTE2VTx?=	MVjkc4V{KG6xdDDpcohq[mm2IFjERWMh[XO\|ZYPz[YQh[XNiaX7jdoVie2ViaX6gbIl{fG:wZTDIN{BtgXOrbnWgNVQh[WOndInsZZRqd25ib3[gSnhPKGenbnW=	NH3XWJkyPjl{MUO2Oy=>
GM15850	MVLLbY5ie2ViQYPzZZk>	NHTG[WczNjVizszN	MmDTPVYhcA>?	MV\EUXNQ	Mn;L[I9meyCwb4SgbY5pcWKrdDDISGFEKGG\|c3Xzd4VlKGG\|IHnuZ5Jm[XOnIHnuJIhqe3SxbnWgTFQhdHm\|aX7lJFUh[WOndInsZZRqd25ib3[gSnhPKGenbnW=	NF3PcXoyPjl{MUO2Oy=>
GM15850	NYX1fGg3U2mwYYPlJGF{e2G7	NUDLfmtrOi53IN88US=>	MoPCPVYhcA>?	MWPEUXNQ	NX;wflhi\G:nczDuc5QhcW6qaXLpeEBJTEGFIHHzd4V{e2WmIHHzJIlv[3KnYYPlJIlvKGirc4TvcoUhUDRibInzbY5mKDF{IHHj[ZR6dGG2aX;uJI9nKE[[TjDn[Y5m	M2e3XlE3QTJzM{[3
GM15850	MXXLbY5ie2ViQYPzZZk>	MkPjNk42KM7:TR?=	NH2zU2c6PiCq	M{PTVWROW09?	MV3kc4V{KG6xdDDpcohq[mm2IFjERWMh[XO\|ZYPz[YQh[XNiaX7jdoVie2ViaX6gbIl{fG:wZTDIN{BtgXOrbnWgPUBi[2W2eXzheIlwdiCxZjDGXG4h\2WwZR?=	MnTPNVY6OjF\|Nke=
GM15850	M1XqZ2tqdmG\|ZTDBd5NigQ>?	NXLORm5MOi53IN88US=>	MVK5OkBp	NVrw[o5bTE2VTx?=	MXzkc4V{KG6xdDDpcohq[mm2IFjERWMh[XO\|ZYPz[YQh[XNiaX7jdoVie2ViaX6gbIl{fG:wZTDIOEBtgXOrbnWgPEBi[2W2eXzheIlwdiCxZjDGXG4h\2WwZR?=	M4nD[VE3QTJzM{[3
GM15850	MlXDT4lv[XOnIFHzd4F6	MWSyMlUh\|ryP	NGnKdJE6PiCq	MmjISG1UVw>?	Mke2[I9meyCwb4SgbY5pcWKrdDDISGFEKGG\|c3Xzd4VlKGG\|IHnuZ5Jm[XOnIHnuJIhqe3SxbnWgTFQhdHm\|aX7lJFE3KGGlZYT5cIF1cW:wIH;mJGZZViCpZX7l	M{nIXlE3QTJzM{[3
GM15850	M33remZ2dmO2aX;uJGF{e2G7	MkD0OUDPxE1?	MXKxNkBp	NUPUfJhNTE2VTx?=	NGjzfFZp[XNibn:g[YZn\WO2IH;uJGZZViCvUl7BJIV5eHKnc4Ppc44>	MWWxOlkzOTN4Nx?=
U937	M4n1eGtqdmG\|ZTDBd5NigQ>?	NVS2WJRYPSEQvF2=	MVGyOEBp	NIHDTJNFVVOR	M3TNbYhieyCwbzDl[oZm[3Rib36gZYxxcGFidIXieYxqdiCjY3X0fYxifGmxbh?=	Mn;NNVc1PDd5NUC=
U937	M2jQOmtqdmG\|ZTDBd5NigQ>?	M3TxblEh\|ryP	MnTrNlQhcA>?	NWPNVWM1TE2VTx?=	MWHoZZMhdm9iZX\m[YN1KG:wIHHsdIhiKHS3YoXsbY4h[WOndInsZZRqd25?	MkHUNVc1PDd5NUC=
PANC1	NVnGc3AzTnWwY4Tpc44hSXO\|YYm=	MYmxJO69VQ>?	MUWyOEBp		MnPW[I9meyCwb4SgbY5kemWjc3WgbY4heDJ5a3nwNUBo\W6nIHX4dJJme3Orb36=	M1[3XVE4PTh6N{S0
PANC1	MnjUSpVv[3Srb36gRZN{[Xl?	M{j3Z\|Eh\|ryP	M13yV\|Q5KCCq		MWHkc4V{KG6xdDDpcoNz\WG\|ZTDpckBxOjetaYCxJIdmdmViZYjwdoV{e2mxbh?=	MVyxO\|U5QDd2NB?=
Caco-2	MVTGeY5kfGmxbjDBd5NigQ>?	MV61JO69VQ>?	MnzNNlQhcA>?	M1zaVmROW09?	MkjZ[I9meyCwb4SgbY5lfWOnIGCyNXdCTjFiZ3Xu[UBmgHC{ZYPzbY9v	NFTaPHQzODF2M{i0NC=>
SCC4	MV;GeY5kfGmxbjDBd5NigQ>?	MVyxJO69VQ>?	NF7FToEyOCCvaX6=	NXjnSIJ2TE2VTx?=	MUnoZZMhdm9iYXfvcol{fCCjY4Tpeol1gSCjdDDWSHIh[XO\|ZYPz[YQh[XNiaX7keYN1cW:wIH;mJGN[WDJ2IHflcoUh\XiycnXzd4lwdg>?	M4eydlIxPDV{MkK1
A549	NXXLeXY1TnWwY4Tpc44hSXO\|YYm=	MlPmOUDPxE1?	NG\Vfmc{KGh?	MkXBSG1UVw>?	NVvoTXlj\G:nczDuc5QhcW6mdXPlJIF2fG:yaHHnfUBie3Onc4Pl[EBieyCrbnPy[YF{\SCrbjDMR\|NKUQ>?	NGXQS2kzODh3NUKwPC=>
HCT116	NVS3V2V1U2mwYYPlJGF{e2G7	MVWwMlMh\|ryP	MlfnN\|AhcA>?	MojZSG1UVw>?	Mk\R[I9meyCwb4SgbY5pcWKrdDDISGFEOSCjc4Pld5Nm\CCjczDpcoR2[3Srb36gc4YhcGm\|dH;u[UBJO0t7IHHj[ZR6dGG2aX;u	MoDvNlExQDB4NEe=
HepG2	M2HCZWZ2dmO2aX;uJGF{e2G7	NHG2Z4cyOCEQvF2=	M2j1SlI1KGh?	MX\EUXNQ	NF\4UYFld2W\|IH7veEBqdmS3Y3WgZZBweHSxc3nzJIF{e2W\|c3XkJIF{KGi7cHXyZYNmfHmuYYTpc44hd2ZicEWz	Ml3PNlE2PDh3OEK=
GM11272	NV63TW5HTnWwY4Tpc44hSXO\|YYm=	MortNE4yKM7:TR?=	M3PmUFczKGh?	NXzs[W5wTE2VTx?=	Mmi0[I9meyCwb4SgdoVi[3SrdnH0[UBO\UOyMjDteZRidnRiZYjwdoV{e2mxbh?=	M3\BbFIyQDRyN{G2
MDA-MB-231	MlnwT4lv[XOnIFHzd4F6	MV2xNEDPxE1?	M4[zXFUhdWmw	NHHzXXlFVVOR	MmDP[I9meyCwb4SgbY5pcWKrdDDISGFEOmF?	NWO4OIpIOjN2OUO0OFk>
MDA-MB-231	NUTIUm1CU2mwYYPlJGF{e2G7	MWSxJO69VQ>?	M2rBbFI1KGh?	MVfEUXNQ	NUTE[\|Zs\G:nczDuc5QhcW6qaXLpeEBJTEGFNjDhd5Nme3OnZDDhd{Bi[2W2eXzheIlwdiCuZY\lcJMhd2ZidIXieYxqdg>?	NFHKVYYzOzR7M{S0PS=>
K562	M2jteGtqdmG\|ZTDBd5NigQ>?				M4jGOYRw\XNibn;0JIlvcGmkaYSgTGRCSw>?	NGKxOFQzOzV7MUGxNS=>
Jurkat	NHmySXpEgXSxdH;4bYMhSXO\|YYm=	NF\EN4YzOCEQvF2=	MVS3NkBp	MWTEUXNQ	M3nreI5wKGO7dH;0c5hq[2m2eTDhd5Nme3OnZDDhd{Boem:5dHigbY5pcWKrdHnvci=>	MknENlQ{ODR\|NEi=
HCT116	MkDrRZBweHSxc3nzJGF{e2G7	MXizJO69VQ>?	NWnPV3JQOjRiaB?=	Mkj0SG1UVw>?	MlHY[I9meyCwb4SgbY5lfWOnIHHwc5B1d3OrczDhd5Nme3OnZDDhd{BqdmO{ZXHz[UBqdiCyNUOgdJJwfGWrbjDs[ZZmdA>?	M3SxcVI1PzZ4NU[w
KASUMI-1	NYXpS3RmT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4fy[GlEPTB;OUmuNVchdk1?	M3zTS3NCVkeHUh?=
KARPAS-45	MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHvOR5lKSzVyPUG3N{45QSCwTR?=	MU\TRW5ITVJ?
BHT-101	NX32NItRT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Mln5TWM2OD1{NESuNVghdk1?	NVXUTpNIW0GQR1XS
H9	M{\tUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MnPjTWM2OD1{NUWuNFQhdk1?	M2jwfXNCVkeHUh?=
PA-1	NUfrb3duT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M{DscGlEPTB;Mki2MlI3KG6P	NVnnUY5VW0GQR1XS
NEC8	NIjXO29Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				Mmq1TWM2OD1{OEmuN\|ghdk1?	MUPTRW5ITVJ?
MHH-PREB-1	NXPldIZGT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NX3vV3pzUUN3ME2yPVQvPTNibl2=	MnnvV2FPT0WU
NB7	M3\lXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MUnJR\|UxRTN2NT63OEBvVQ>?	NIXUeZJUSU6JRWK=
A3-KAW	NXLsUpNLT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M2DOd2lEPTB;NECwMlU6KG6P	NFq2W3dUSU6JRWK=
NB69	NYTTPFU{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MUXJR\|UxRTRzMT63NUBvVQ>?	MmD1V2FPT0WU
EoL-1-cell	Ml3OS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3HTWWlEPTB;NEW0NlUhdk1?	MUTTRW5ITVJ?
CHP-212	M3PNPWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M{j6cGlEPTB;NEW3MlU{KG6P	NFTVNHZUSU6JRWK=
C2BBe1	NEm1XGdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NUTYVG9KUUN3ME20O\|IvOTlibl2=	MUDTRW5ITVJ?
697	MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHO1bZpKSzVyPUS3N{41OSCwTR?=	NGDMPYRUSU6JRWK=
BCPAP	NYXJfnlUT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NEPyUndKSzVyPUWwNU41OiCwTR?=	M{\PbHNCVkeHUh?=
L-363	MkLvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MoX4TWM2OD13MEOuNUBvVQ>?	NUD4d5hNW0GQR1XS
ES8	M3XpXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NYqzRXV3UUN3ME21NlMvPTNibl2=	NVHXV5R[W0GQR1XS
BE-13	MkPqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M4CzOWlEPTB;NUK2Mlk3KG6P	MX7TRW5ITVJ?
CTB-1	M1zadWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NV3iVXBSUUN3ME21N\|cvQTJibl2=	MVfTRW5ITVJ?
HD-MY-Z	M3v6RWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M1KwSWlEPTB;NUO4MlE{KG6P	M2jiXXNCVkeHUh?=
NKM-1	MkLxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MlriTWM2OD13NESuNlchdk1?	MXfTRW5ITVJ?
NCI-H720	MoTpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MkC1TWM2OD13NkCuNVghdk1?	NXjHb3I6W0GQR1XS
KY821	Mli0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWLVTGtIUUN3ME21OlMvOjVibl2=	MnrmV2FPT0WU
OVCAR-5	MnOwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MWXJR\|UxRTV5Nj6xNUBvVQ>?	M2rlNXNCVkeHUh?=
CTV-1	NHTHbXFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MoXZTWM2OD13OEGuOVYhdk1?	MYDTRW5ITVJ?
P12-ICHIKAWA	MkLrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NGnNc2ZKSzVyPUW5Ok42OSCwTR?=	NY[5XlBnW0GQR1XS
DB	MmL4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Ml\JTWM2OD13OUiuOVchdk1?	NWLUclVGW0GQR1XS
CHL-1	NFXMOWdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHfPWIpKSzVyPU[0Nk4xQCCwTR?=	NVjmT\|FOW0GQR1XS
A4-Fuk	M3jmV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M1HNN2lEPTB;NkS0MlkyKG6P	NVuzNWdGW0GQR1XS
MV-4-11	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHjq[ZhKSzVyPU[1PU4yKG6P	NHr6dHFUSU6JRWK=
RPMI-8226	MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MmTYTWM2OD14N{iuNVghdk1?	NUPaOHZ7W0GQR1XS
NB14	MkP6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NFfDSFBKSzVyPU[5Ok46PSCwTR?=	MX7TRW5ITVJ?
DOHH-2	MoTSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MUnJR\|UxRTdyNj62PEBvVQ>?	NV\PXFV7W0GQR1XS
D-423MG	NHz1c\|ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NGjOcIFKSzVyPUewOk45QSCwTR?=	MmHJV2FPT0WU
D-283MED	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NIXvb5VKSzVyPUexOE4yPCCwTR?=	NFvSeI5USU6JRWK=
ES1	Mo\uS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NX3UUFlDUUN3ME23NlQvPCCwTR?=	NHLze4hUSU6JRWK=
GOTO	NV3icmdiT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3OxOGlEPTB;N{K5MlEzKG6P	MnjHV2FPT0WU
NCI-H209	M2TLNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MlnkTWM2OD15MkmuPUBvVQ>?	MVXTRW5ITVJ?
MOLT-13	NI\PSZpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M{\HZWlEPTB;N{O4Mlk5KG6P	NVrRPXZFW0GQR1XS
ATN-1	NFixRWxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MlnnTWM2OD15NECuNlghdk1?	MVvTRW5ITVJ?
DU-4475	NFLC[FdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MX3JR\|UxRTd3MT65NUBvVQ>?	M37Xe3NCVkeHUh?=
NB10	MnfjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MojlTWM2OD15NUGuPVIhdk1?	MkPrV2FPT0WU
KG-1	MknPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NEfGeXJKSzVyPUe3OU41PSCwTR?=	MnvUV2FPT0WU
MOLT-4	M2HqNWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mni0TWM2OD15OEeuOFYhdk1?	NI\nbmtUSU6JRWK=
TE-1	MoO3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NW\Teo5bUUN3ME23PVEvOSCwTR?=	NWT5T5psW0GQR1XS
SBC-1	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MmLnTWM2OD15OUOuPFQhdk1?	M{\tSHNCVkeHUh?=
HEL	NUO1dnFoT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NV;peHFNUUN3ME24NFYvODhibl2=	MknNV2FPT0WU
SK-MEL-2	Mn7XS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NHnXVHFKSzVyPUiwPU41PCCwTR?=	M{XJR3NCVkeHUh?=
KU812	NGjSW\|VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NVy0OWNKUUN3ME24NVMvOSCwTR?=	MmnDV2FPT0WU
RPMI-8866	MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NXO4[lRmUUN3ME24NVMvPjdibl2=	M3jNSnNCVkeHUh?=
ALL-PO	MnftS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NXWy[VllUUN3ME24NVQvPjZibl2=	M3nEZnNCVkeHUh?=
LU-139	NUjVeo1HT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NF6zdoVKSzVyPUiyNk45PiCwTR?=	MnXFV2FPT0WU
RS4-11	MlrES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MnnlTWM2OD16M{KuOFUhdk1?	NGLKcJNUSU6JRWK=
EW-18	M2nQUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MVvJR\|UxRTh\|Mj65OkBvVQ>?	MV;TRW5ITVJ?
P30-OHK	NHnNSXBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWDMZnZ[UUN3ME24N\|UvPyCwTR?=	NILrd\|NUSU6JRWK=
D-566MG	MmLiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWnQbolbUUN3ME24N\|gvPjJibl2=	MojVV2FPT0WU
HSC-4	M{nuR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGrrV4VKSzVyPUi0Ok42OSCwTR?=	MnyyV2FPT0WU
QIMR-WIL	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MX7JR\|UxRTh4Mj6wN{BvVQ>?	MVHTRW5ITVJ?
SW954	NWfDUodHT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MYLJR\|UxRTh4Mz6xOkBvVQ>?	MlXUV2FPT0WU
HGC-27	Moi5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MV3JR\|UxRTh5Mj6zOEBvVQ>?	MX\TRW5ITVJ?
HH	NFjLT4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M{HVPGlEPTB;OEm0MlEzKG6P	NGrsSY9USU6JRWK=
KE-37	M1vHO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MXzJR\|UxRTh7ND62NkBvVQ>?	NEKwUFRUSU6JRWK=
SK-N-DZ	MlqwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1Tyc2lEPTB;OUCwMlQ{KG6P	NEj6[mlUSU6JRWK=
J-RT3-T3-5	NU\4c49jT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NIfpUHBKSzVyPUmxNE41QSCwTR?=	NH\Ofo1USU6JRWK=
A427	MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M{eyfWlEPTB;OUKwMlg1KG6P	NGjub2FUSU6JRWK=
ECC10	NGf5cXpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				Mlu0TWM2OD17NEWuPFchdk1?	MULTRW5ITVJ?
EW-1	MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MV;JR\|UxRTl2Nz6yOkBvVQ>?	Mlr4V2FPT0WU
MIA-PaCa-2	MmDDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MUjJR\|UxRTl2OT6xNkBvVQ>?	MVzTRW5ITVJ?
HCC2218	M{S3d2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MWLJR\|UxRTl3OD60PEBvVQ>?	MVLTRW5ITVJ?
HAL-01	NIrMZlNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MmnaTWM2OD17NkiuNFQhdk1?	MlrGV2FPT0WU
RD	NX[5eYZZT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NFPFWJVKSzVyPUm3OE41PSCwTR?=	NFHNfXhUSU6JRWK=
SK-N-AS	NGDGPHVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MUTJR\|UxRTl6OD6xJI5O	NILaPGJUSU6JRWK=
ML-2	NYTYOZV7T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4PjXGlEPTB;MT6wNFQxPyEQvF2=	NEHMeYZUSU6JRWK=
MEL-HO	MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHnKToZKSzVyPUGuNFA2QDJizszN	NFjQWo1USU6JRWK=
MS-1	MmXYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mn3oTWM2OD1zLkCwOlE4KM7:TR?=	NF3Bb2hUSU6JRWK=
NCI-SNU-1	MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHP0N3hKSzVyPUGuNFI{OzFizszN	M1;JTHNCVkeHUh?=
8505C	MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NI[2RnVKSzVyPUGuNFI{OzFizszN	MmXJV2FPT0WU
MN-60	MkP6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MXvJR\|UxRTFwMEK2PEDPxE1?	M3y0VXNCVkeHUh?=
SAS	NHq4fYdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MXfJR\|UxRTFwMESwPFEh\|ryP	MUPTRW5ITVJ?
EFM-19	NX\YdXIzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Mk\ETWM2OD1zLkC0PFc6KM7:TR?=	NV\BTGtuW0GQR1XS
Ca9-22	NVu0RXdvT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M2T2TmlEPTB;MT6wOVExPyEQvF2=	NVrwWVZ5W0GQR1XS
NBsusSR	MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MWHJR\|UxRTFwMEWxOlYh\|ryP	MX7TRW5ITVJ?
NB13	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Ml\tTWM2OD1zLkC1OVAyKM7:TR?=	MUDTRW5ITVJ?
SF295	NH3E[GdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NEjBe4xKSzVyPUGuNFY3OjRizszN	MlvUV2FPT0WU
U-2-OS	NWfpdo1DT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NHG4OYpKSzVyPUGuNFc6OTFizszN	MkPGV2FPT0WU
NCI-H526	MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MV;JR\|UxRTFwMEiyPVEh\|ryP	NXLxSIdPW0GQR1XS
KMOE-2	MkXNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2TBVGlEPTB;MT6wPVQzOiEQvF2=	NHj4TXhUSU6JRWK=
RCM-1	MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3nKeWlEPTB;MT6xNlExOiEQvF2=	MmH3V2FPT0WU
MC116	NWTVUldrT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVPJR\|UxRTFwMUO2NlEh\|ryP	NIfQcJBUSU6JRWK=
NCI-H1092	NWW0OnhmT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NUXDVWV[UUN3ME2xMlE2PDB4IN88US=>	NH7KUGZUSU6JRWK=
EW-3	MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NXjMUWFzUUN3ME2xMlE4OjF{IN88US=>	NI\5TZlUSU6JRWK=
HCT-116	MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NWHFeGhoUUN3ME2xMlE4PzVizszN	NIXEXYxUSU6JRWK=
MC-IXC	MkL1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3HNWmlEPTB;MT6xO\|g5OSEQvF2=	NXS0O4hwW0GQR1XS
LB1047-RCC	MXPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NX7DT\|E6UUN3ME2xMlE5OzF{IN88US=>	Ml2yV2FPT0WU
VM-CUB-1	M13aUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NX3XUoZbUUN3ME2xMlE6OTB6IN88US=>	M3L1[XNCVkeHUh?=
NB5	MkjNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NEDwfWhKSzVyPUGuNVk5PTZizszN	NVfPeoQ4W0GQR1XS
SKG-IIIa	NHvZdmRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NYTXcpZnUUN3ME2xMlI{PDZ2IN88US=>	NYDUUmh4W0GQR1XS
HO-1-N-1	NGLwenJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NVK5WWlDUUN3ME2xMlI{QDN3IN88US=>	NXGx[ZBvW0GQR1XS
EFO-27	NHjmS2NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MXXJR\|UxRTFwMkWwOFMh\|ryP	NFrlW\|NUSU6JRWK=
MHH-NB-11	M2TEemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NInEVJZKSzVyPUGuNlg{OjlizszN	MVHTRW5ITVJ?
SW620	NWXuRVN{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NV;lNHhDUUN3ME2xMlI6ODF6IN88US=>	NITwV3lUSU6JRWK=
MOLT-16	MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NH:yfoJKSzVyPUGuNlk4QTdizszN	Mmf1V2FPT0WU
NTERA-S-cl-D1	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NXLuVW9UUUN3ME2xMlMyPzZzIN88US=>	MVjTRW5ITVJ?
VA-ES-BJ	NWXGe3U4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NUnMPG5FUUN3ME2xMlMzPDd5IN88US=>	MkfBV2FPT0WU
HCC1419	M37sZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M3PpZWlEPTB;MT6zOFAzPyEQvF2=	MU\TRW5ITVJ?
NCI-H69	NIDmZ2FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MWTJR\|UxRTFwM{SxNVIh\|ryP	M4LITHNCVkeHUh?=
DEL	M4DMSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MW\JR\|UxRTFwM{WxOlIh\|ryP	NFnBV2JUSU6JRWK=
LXF-289	NGq2SIRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHntWoFKSzVyPUGuN\|UzPCEQvF2=	Mn;6V2FPT0WU
EW-11	MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M{DpSmlEPTB;MT6zOlAzPiEQvF2=	MlP4V2FPT0WU
KP-4	NEThR\|ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M1uxOGlEPTB;MT6zO\|A5PSEQvF2=	MYnTRW5ITVJ?
NOS-1	MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M1[yN2lEPTB;MT60NVE6PCEQvF2=	NGH1SG5USU6JRWK=
SK-NEP-1	NUCxVnVVT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MUDJR\|UxRTFwNEG2PVMh\|ryP	NHntOXpUSU6JRWK=
LAMA-84	MlHCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MkezTWM2OD1zLkSzPVQ2KM7:TR?=	MmnyV2FPT0WU
ES5	M3m2eWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M1jicWlEPTB;MT60OFMh\|ryP	M3rLcXNCVkeHUh?=
HuO9	Ml7pS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWLEU\|dbUUN3ME2xMlQ2OzZ{IN88US=>	M3HycHNCVkeHUh?=
COLO-684	NF7BWGZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MUHJR\|UxRTFwNE[xNVgh\|ryP	NHHVUZhUSU6JRWK=
EW-24	Mn3aS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MWnJR\|UxRTFwNE[1N\|Eh\|ryP	MWDTRW5ITVJ?
BV-173	NVvQ[IFxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MY\JR\|UxRTFwNEeyPVEh\|ryP	MofMV2FPT0WU
NCI-H1770	MX;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MWXJR\|UxRTFwNEi1N\|Yh\|ryP	M{nQNHNCVkeHUh?=
HuP-T4	MnHQS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MVLJR\|UxRTFwNEmzJO69VQ>?	MmPGV2FPT0WU
TYK-nu	MofxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1LpcGlEPTB;MT60PVg2OSEQvF2=	M1fDUnNCVkeHUh?=
YH-13	NW\kTop7T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Mn7BTWM2OD1zLkS5PFk1KM7:TR?=	M2PqVXNCVkeHUh?=
H4	NGmxcotIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MorwTWM2OD1zLkWwPVEzKM7:TR?=	MoG1V2FPT0WU
OVCAR-8	Mn[5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MkjRTWM2OD1zLkW0OFc4KM7:TR?=	MV7TRW5ITVJ?
NCI-H23	NVHXb5o5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MV;JR\|UxRTFwNUS2OFUh\|ryP	M2\SRnNCVkeHUh?=
ES7	MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NWG2PWRJUUN3ME2xMlU1Pzd\|IN88US=>	NWDCOlVtW0GQR1XS
COR-L88	MljGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MoHvTWM2OD1zLkW2OFI1KM7:TR?=	NVnnVo1NW0GQR1XS
TI-73	MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NVPEO2ZPUUN3ME2xMlU6ODZizszN	MX7TRW5ITVJ?
RT-112	M1rz[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MlnVTWM2OD1zLkW5Nlg1KM7:TR?=	MXfTRW5ITVJ?
HuO-3N1	NHrHdW1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MnjUTWM2OD1zLkW5N\|g2KM7:TR?=	NHn1PHdUSU6JRWK=
HC-1	MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHzvPJlKSzVyPUGuOVk5PjZizszN	NGnnR5VUSU6JRWK=
HT55	M4LIXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M1TvU2lEPTB;MT62OVE{OSEQvF2=	MWLTRW5ITVJ?
IA-LM	M4DJc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NFzDfmxKSzVyPUGuOlkzPzhizszN	NIDVZVhUSU6JRWK=
EM-2	M3rtWmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2XBcmlEPTB;MT63NFAyPCEQvF2=	NIH1b\|dUSU6JRWK=
MHH-ES-1	NYnNNHJ{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MmjDTWM2OD1zLkewOFM2KM7:TR?=	NIexZmNUSU6JRWK=
CAL-27	NHfhNG9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXXSN3JpUUN3ME2xMlcxPjJzIN88US=>	MYHTRW5ITVJ?
COLO-800	NFLkUIlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXfweoZWUUN3ME2xMlcyOTd7IN88US=>	MmHSV2FPT0WU
HCE-T	M1Gwb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NVnYb5E1UUN3ME2xMlcyPSEQvF2=	MX3TRW5ITVJ?
CAMA-1	MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkLWTWM2OD1zLkexPVcyKM7:TR?=	NVmzVI9ZW0GQR1XS
LOXIMVI	NGSzV3FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MoHsTWM2OD1zLkeyNVEh\|ryP	M13MbnNCVkeHUh?=
NH-12	Ml;nS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MknwTWM2OD1zLkeyOlkyKM7:TR?=	Ml7KV2FPT0WU
TCCSUP	NHHmRohIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXPJZm9bUUN3ME2xMlczQDJ7IN88US=>	NH23TYdUSU6JRWK=
MDA-MB-361	NHvIcVZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MoDsTWM2OD1zLkezNVU4KM7:TR?=	NYfVNIpDW0GQR1XS
EW-16	NV;IXpUzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3nyOmlEPTB;MT63OFExPyEQvF2=	NH\3[VhUSU6JRWK=
SNU-423	MlKyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NEXNWnlKSzVyPUGuO\|U5OjdizszN	NHvsZ5BUSU6JRWK=
Daoy	NF62T3hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFPze\|RKSzVyPUGuO\|Y{OTlizszN	MnH6V2FPT0WU
ES4	MonYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NYDVWYNJUUN3ME2xMlc5PzRzIN88US=>	NWfQSlYxW0GQR1XS
PFSK-1	MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NIW3VVJKSzVyPUGuPFA{PyEQvF2=	MnjMV2FPT0WU
ES3	M1jQfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MnnUTWM2OD1zLkiyOlgyKM7:TR?=	NFzYN4lUSU6JRWK=
ONS-76	MlfDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Ml3zTWM2OD1zLkiyPFk4KM7:TR?=	MXnTRW5ITVJ?
JVM-3	NEDtUYdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MmW2TWM2OD1zLki1OFUyKM7:TR?=	NGDvS3lUSU6JRWK=
OS-RC-2	MoDUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NFnIRlNKSzVyPUGuPFcyPTFizszN	NU[4NZg4W0GQR1XS
COLO-320-HSR	MoL6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWXKS5JnUUN3ME2xMlg5OTl5IN88US=>	Ml\lV2FPT0WU
HN	NFH0U4JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M2rtZ2lEPTB;MT64PFczPSEQvF2=	M13CWHNCVkeHUh?=
HT	NWrtU5JxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGTFVFJKSzVyPUGuPFg6PDdizszN	NHz4bXhUSU6JRWK=
LoVo	MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NH;wdmJKSzVyPUGuPFk5OSEQvF2=	MX;TRW5ITVJ?
CGTH-W-1	MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NVLweJB1UUN3ME2xMlg6QTR4IN88US=>	M2LYZ3NCVkeHUh?=
NB6	NX[yXo5kT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M{XocGlEPTB;MT65NVI6QCEQvF2=	NGnDeVhUSU6JRWK=
EW-22	MkTMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWrKdlVQUUN3ME2xMlkzQDh5IN88US=>	NHjQfJZUSU6JRWK=
ES6	M{LaW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NHH3NFhKSzVyPUGuPVM3OzFizszN	NECxU\|JUSU6JRWK=
SCC-15	NXTlU4ZPT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NIrRVVJKSzVyPUGuPVM5OTlizszN	NYSyfVF3W0GQR1XS
HL-60	NHjoWGRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MnTNTWM2OD1zLkmzPVAzKM7:TR?=	MWjTRW5ITVJ?
human HOP-92	NFTjN5FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MnnsTWM2OD1zLkm0NFY2KM7:TR?=	MUXTRW5ITVJ?
SW626	M3LIbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M371RWlEPTB;MT65OFg6QSEQvF2=	NVPVOWg1W0GQR1XS
HEC-1	NFLnSoFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NYL3Z5B7UUN3ME2xMlk2OzZizszN	MnfsV2FPT0WU
LB2241-RCC	M4PydGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2TYVmlEPTB;MT65PFI{OSEQvF2=	M{jHVHNCVkeHUh?=
Ramos-2G6-4C10	MmfSS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M4q5emlEPTB;MT65PVQ6OyEQvF2=	M1LJ[nNCVkeHUh?=
A101D	MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnHmTWM2OD1{LkKwN\|A{KM7:TR?=	NWD1bndLW0GQR1XS
NCI-H446	M2jiN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2jUXGlEPTB;Mj6wOFU6QSEQvF2=	MWDTRW5ITVJ?
SBC-5	NUPLVXRnT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MmDOTWM2OD1{LkC2NVQ4KM7:TR?=	NHzCeZhUSU6JRWK=
HOS	NGO4OGJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MlrXTWM2OD1{LkC3OlU{KM7:TR?=	NGS4Wo1USU6JRWK=
K5	NWjndHZbT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1[ycWlEPTB;Mj6wO\|gyOSEQvF2=	NE[1UFFUSU6JRWK=
HLE	NHG0SlhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				Ml3FTWM2OD1{LkC4OVI6KM7:TR?=	MVXTRW5ITVJ?
HSC-2	Mn71S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M{LBdmlEPTB;Mj6xNlg6QCEQvF2=	MUXTRW5ITVJ?
LCLC-97TM1	MoO4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWeyXXFWUUN3ME2yMlE1PTh\|IN88US=>	MnPnV2FPT0WU
DMS-273	MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NEfM[oNKSzVyPUKuNVQ5OzdizszN	NXXvWHN3W0GQR1XS
TE-8	M37WSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M1Xq[2lEPTB;Mj6xOVc3PSEQvF2=	MUjTRW5ITVJ?
DSH1	M3T2NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M1jH[2lEPTB;Mj6xOlM6QCEQvF2=	MYnTRW5ITVJ?
CAL-51	M2\mV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGj4O2ZKSzVyPUKuNVY3QTlizszN	NUDqUoJVW0GQR1XS
IST-SL1	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MVXJR\|UxRTJwMU[4OFQh\|ryP	Ml\kV2FPT0WU
GCT	NH\zd4xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MX;JR\|UxRTJwMUe3O{DPxE1?	NGS0R5dUSU6JRWK=
SW948	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NFj1eo5KSzVyPUKuNVg1PTZizszN	M2fNSnNCVkeHUh?=
NOMO-1	MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NWTlVmg2UUN3ME2yMlE6OzF5IN88US=>	M3vHO3NCVkeHUh?=
C8166	M{jGN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MWTJR\|UxRTJwMkGzN\|Qh\|ryP	NHH4XIVUSU6JRWK=
OC-314	NUGxdYtsT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Mmm1TWM2OD1{LkKzNlU6KM7:TR?=	M4nGVXNCVkeHUh?=
CAL-39	M2PpOGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MkXXTWM2OD1{LkKzOlI3KM7:TR?=	M{LKTHNCVkeHUh?=
MDA-MB-453	M2S1c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NV\FUVJ{UUN3ME2yMlI1Ojd3IN88US=>	MoLZV2FPT0WU
A673	MljqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MWTJR\|UxRTJwMkW4OlIh\|ryP	MUXTRW5ITVJ?
HTC-C3	MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MortTWM2OD1{LkK2PFUh\|ryP	MkLKV2FPT0WU
NCI-H1666	M3X1PWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2m4UmlEPTB;Mj6yPFEyOSEQvF2=	MoLSV2FPT0WU
PSN1	NUPSbHZqT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVHJR\|UxRTJwMki5NVMh\|ryP	NIDLO3JUSU6JRWK=
GI-1	M{mwUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NIn4WlhKSzVyPUKuN\|A2PDNizszN	MnH2V2FPT0WU
HuH-7	MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NImxbGlKSzVyPUKuN\|A3OzdizszN	MnHIV2FPT0WU
JAR	M37rb2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M{\tN2lEPTB;Mj6zNVk5PyEQvF2=	M2j1enNCVkeHUh?=
5637	NE\sblNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MUTJR\|UxRTJwM{KxNlkh\|ryP	NILONWRUSU6JRWK=
GB-1	M17lSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MkK1TWM2OD1{LkOyN\|M2KM7:TR?=	MVXTRW5ITVJ?
KP-N-YS	M2PTNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2D0Z2lEPTB;Mj6zNlYyPSEQvF2=	M3m4XnNCVkeHUh?=
OAW-42	M2rzVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NVqyXGR4UUN3ME2yMlM{PDF4IN88US=>	NFKxfVlUSU6JRWK=
8-MG-BA	M2rne2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NYPSTlY{UUN3ME2yMlM{QTB4IN88US=>	NYi0WGtbW0GQR1XS
RH-18	MljjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NGTicJdKSzVyPUKuN\|UxOjJizszN	NEHCblNUSU6JRWK=
NCI-H1155	MknCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MmHuTWM2OD1{LkO2O\|I2KM7:TR?=	NHP4PXhUSU6JRWK=
NB17	NV3OXIlLT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NYDPb49KUUN3ME2yMlM5OjR\|IN88US=>	M{LYU3NCVkeHUh?=
NCI-H1437	NFjSWmtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MVvJR\|UxRTJwNEG4O\|Mh\|ryP	NHX1O3BUSU6JRWK=
SN12C	NXzYZY1FT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVHJR\|UxRTJwNEOyNVQh\|ryP	NEe0Z2xUSU6JRWK=
HSC-3	M3fLRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MmDRTWM2OD1{LkS0OVA6KM7:TR?=	NUPMUHFmW0GQR1XS
GAMG	M{Hk[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MkO4TWM2OD1{LkS0OVYyKM7:TR?=	NVi0bpc6W0GQR1XS
HT-1080	M{jkU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Ml;zTWM2OD1{LkS0PFY1KM7:TR?=	NIjuWopUSU6JRWK=
A549	NILjRYxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MW\JR\|UxRTJwNES4PVMh\|ryP	NVTFZmFnW0GQR1XS
KNS-62	MlO0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NIPnfYhKSzVyPUKuOFUxPjFizszN	MUTTRW5ITVJ?
YKG-1	NILHcFNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NGTWbHFKSzVyPUKuOFU1OzdizszN	MVTTRW5ITVJ?
LU-134-A	MXTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NXTDbnh{UUN3ME2yMlQ4ODB6IN88US=>	M2roZ3NCVkeHUh?=
FADU	NGn3SY9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4roNGlEPTB;Mj60O\|E3OiEQvF2=	NYfkdFZ[W0GQR1XS
TGBC11TKB	NVfGd3VzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVnJR\|UxRTJwNEexO\|ch\|ryP	Ml\TV2FPT0WU
HT-3	NVjodpdKT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGnleZRKSzVyPUKuOFk2OzVizszN	NV;3c3FyW0GQR1XS
NCI-H2170	MnPBS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MonYTWM2OD1{LkWwOVQ6KM7:TR?=	M2iycXNCVkeHUh?=
Mo-T	MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MWPJR\|UxRTJwNUC5Nlch\|ryP	MVrTRW5ITVJ?
CCRF-CEM	MUHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHTjb\|VKSzVyPUKuOVMxPDNizszN	NIrUd2lUSU6JRWK=
KU-19-19	NFz6N4RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXHWWGJwUUN3ME2yMlU{PTF\|IN88US=>	NITCdnhUSU6JRWK=
NCI-H1048	M1L0[Wdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MYrJR\|UxRTJwNUWwNlUh\|ryP	MXjTRW5ITVJ?
KOSC-2	M1vET2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NYnTUXp6UUN3ME2yMlU3ODd4IN88US=>	NELxUmlUSU6JRWK=
A431	NVHnWZpWT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NHzMXJRKSzVyPUKuOVY{OzVizszN	M4HROHNCVkeHUh?=
COR-L23	M3zaZWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MmfHTWM2OD1{LkW4OVY3KM7:TR?=	MYnTRW5ITVJ?
MKN28	MmHDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MXnJR\|UxRTJwNUmwN\|ch\|ryP	NVWzNFVWW0GQR1XS
22RV1	M3q4PGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MXPJR\|UxRTJwNUmyO\|Qh\|ryP	M3HHRXNCVkeHUh?=
ABC-1	MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MorDTWM2OD1{Lk[wOFYh\|ryP	NUm5d3NpW0GQR1XS
NCI-H2126	NH7mbndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M2DpVGlEPTB;Mj62NFk5PCEQvF2=	MnLUV2FPT0WU
DoTc2-4510	MnnrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Ml3GTWM2OD1{Lk[yNVg2KM7:TR?=	M1fnSnNCVkeHUh?=
SCC-4	MXXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnzyTWM2OD1{Lk[zNFEzKM7:TR?=	NInYOW1USU6JRWK=
NCI-H661	NF7Be3FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXu1R2ZIUUN3ME2yMlY1ODh3IN88US=>	Ml7PV2FPT0WU
RPMI-2650	NUPnS3JvT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NXXETVdsUUN3ME2yMlY1OTR\|IN88US=>	M13XU3NCVkeHUh?=
NCI-H510A	M1PUVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MWHJR\|UxRTJwNkS0NlYh\|ryP	Mme3V2FPT0WU
BPH-1	NH;kTpdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MWLJR\|UxRTJwNkW4OUDPxE1?	MYXTRW5ITVJ?
M14	MmnKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NVi2[GRzUUN3ME2yMlY3QTl\|IN88US=>	M{C0SnNCVkeHUh?=
G-402	NGLzOIVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MWHJR\|UxRTJwN{C0OVEh\|ryP	MlXoV2FPT0WU
AsPC-1	MkPiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MVvJR\|UxRTJwN{GxO{DPxE1?	NHPMUoxUSU6JRWK=
NB12	MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M{\J[WlEPTB;Mj63NVcyKM7:TR?=	MXvTRW5ITVJ?
SK-HEP-1	MnT4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M4K4dWlEPTB;Mj63OFM6OSEQvF2=	NXnRTVRvW0GQR1XS
U-266	M{fPcWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M3nVc2lEPTB;Mj63O\|EzOSEQvF2=	M4[2XXNCVkeHUh?=
AM-38	MkP0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M4H6emlEPTB;Mj63O\|M2PSEQvF2=	M1jQS3NCVkeHUh?=
PC-14	MmH5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2TafmlEPTB;Mj64NFUyKM7:TR?=	NGTGTm5USU6JRWK=
EGI-1	Moe1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1viW2lEPTB;Mj64NVc1OyEQvF2=	MXzTRW5ITVJ?
LS-411N	MnfES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MVnJR\|UxRTJwOEKzN{DPxE1?	NFjlPXpUSU6JRWK=
BFTC-905	NIjPe4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MY\JR\|UxRTJwOEW1NlMh\|ryP	NULpXlZOW0GQR1XS
CaR-1	M133W2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MXLJR\|UxRTJwOE[g{txO	NF6xOIdUSU6JRWK=
NCI-H292	NH\mSndIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NVvJV41kUUN3ME2yMlg3PTl4IN88US=>	NELiUGJUSU6JRWK=
8305C	MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Mn3sTWM2OD1{Lki2OlQ2KM7:TR?=	NVeyR\|ltW0GQR1XS
SNU-449	NVSySnVtT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MYjJR\|UxRTJwOEmxPFIh\|ryP	NHe5Xm5USU6JRWK=
LCLC-103H	M2XBemdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M3\lPWlEPTB;Mj65NFQ{QCEQvF2=	NVXkeGVoW0GQR1XS
SW1573	MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MlftTWM2OD1{Lkm2NFgzKM7:TR?=	NFXQfolUSU6JRWK=
MLMA	MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M4PNNmlEPTB;Mj65OlcyPyEQvF2=	Mn;0V2FPT0WU
NCI-H1355	MWjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MX\JR\|UxRTNwMEC3PVYh\|ryP	MkizV2FPT0WU
RMG-I	MnHaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2fiSmlEPTB;Mz6wNlU6OiEQvF2=	MlTIV2FPT0WU
BB65-RCC	MojnS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MlLuTWM2OD1\|LkCzN\|E1KM7:TR?=	NYq5TXR{W0GQR1XS
PC-3	MmTvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1HlcWlEPTB;Mz6wN\|g4PCEQvF2=	M4nJVHNCVkeHUh?=
SF268	NWrXUJY2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MnrHTWM2OD1\|LkC0OVI{KM7:TR?=	M2m5SXNCVkeHUh?=
NCI-H810	NVz2UVBkT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Mnz1TWM2OD1\|LkC0PFI{KM7:TR?=	MX3TRW5ITVJ?
MEG-01	M{XGUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2[4V2lEPTB;Mz6wOlE3PCEQvF2=	Mm\SV2FPT0WU
SW13	M4XHdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NIfrT\|VKSzVyPUOuNFc5PDdizszN	NVrncI1DW0GQR1XS
RH-1	MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MXrJR\|UxRTNwMUCyO\|gh\|ryP	NHfFT2pUSU6JRWK=
GT3TKB	NWr1e5R7T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MoXoTWM2OD1\|LkGxNlg{KM7:TR?=	MVHTRW5ITVJ?
TK10	MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NUHD[4xEUUN3ME2zMlE{PzJ2IN88US=>	NETxSYVUSU6JRWK=
T-24	MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M4OzdmlEPTB;Mz6xOVA4KM7:TR?=	MmjWV2FPT0WU
A498	MmS0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NVLtRoJrUUN3ME2zMlIxQDdzIN88US=>	NGPpfmFUSU6JRWK=
GR-ST	Mn7kS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NUO2WYt{UUN3ME2zMlIzOTN7IN88US=>	NY\xPXhWW0GQR1XS
LB2518-MEL	MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NGXidWRKSzVyPUOuNlI{QThizszN	MWDTRW5ITVJ?
T47D	MoGxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M4DCbWlEPTB;Mz6yN\|YzPyEQvF2=	MYDTRW5ITVJ?
NCI-H1651	NVfjPIZWT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NV7JUo1ZUUN3ME2zMlI1PjR2IN88US=>	NYO3Zm9rW0GQR1XS
EC-GI-10	M1fKTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXPXWXhpUUN3ME2zMlI3OTV\|IN88US=>	NV3GbXdFW0GQR1XS
HT-29	NXnwT4R[T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVPJR\|UxRTNwMk[2NVQh\|ryP	M175S3NCVkeHUh?=
GI-ME-N	MlG5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1X1d2lEPTB;Mz6yPVUyOSEQvF2=	NYTGNpE4W0GQR1XS
SW756	NFPmVnFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=

研究领域